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I 
Abstract 
The phylum Cnidaria (corals, sea pens, sea anemones, jellyfish and hydroids) is the oldest 
venomous animal lineage (~750 million years old), making it an ideal phylum to understand the 
origin and diversification of venom. Cnidarians are characterised by specialised cellular structures 
called cnidae, which they utilise to inject mixtures of bioactive compounds or venom for predation 
and defence. In recent years cnidarian venoms have begun to be investigated as a potential source of 
novel bioactive therapeutics. However, in comparison with several venomous lineages that are 
relatively younger, such as snakes, cone snails and spiders, the diversification and molecular 
evolutionary regimes of toxins encoded by these fascinating and ancient animals remain poorly 
understood. 
The first experimental part of this thesis (Chapter 2) is comprised of the phylogenetic and molecular 
evolutionary histories of pharmacologically characterised cnidarian toxin families. These include 
peptide neurotoxins (voltage-gated Na
+
 and K
+
 channel-targeting toxins: NaTxs and KTxs, 
respectively), pore-forming toxins (actinoporins, aerolysin-related toxins, and jellyfish toxins) and 
small cysteine-rich peptides (SCRiPs). Our analyses show that most cnidarian toxins remain 
conserved under the strong influence of negative selection. A deeper analysis of the molecular 
evolutionary histories of neurotoxins demonstrates that type III KTxs have evolved from NaTxs 
under the regime of positive selection and likely represent a unique evolutionary innovation of the 
Actinioidea lineage. We also identify a few functionally important sites in other classes of 
neurotoxins and pore-forming toxins that experienced episodic adaptation. In addition, we describe 
the first family of neurotoxic peptides (SCRiPs) in reef-building corals, Acropora millepora, that 
are likely involved in the envenoming function. 
The third chapter describes the development of a novel venom extraction technique which is rapid, 
repeatable and cost effective. This technique involves using ethanol to both induce cnidae discharge 
and to recover venom contents in one step. Our model species is the notorious Australian box 
jellyfish (Chironex fleckeri) which has a notable impact on public health. By using the 
complementary approaches of transcriptomics, proteomics, mass spectrometry, histology, and 
scanning electron microscopy, this study compares the proteome profile of the new ethanol 
recovery based method to a previously reported protocol, based upon density purified intact cnidae 
and pressure induced disruption. This work not only results in the expansion of identified Australian 
box jellyfish venom components but also illustrates that ethanol extraction method could greatly 
augment future cnidarian venom proteomics research efforts. 
The forth chapter is constituted by previously described venom extraction technique, ethanol-
induced discharge of cnidae, to rapidly and efficiently characterise venom components of the Jelly 
Blubber or Blue Blubber Jellyfish, Catostylus mosaicus. By using a combination of proteomics and 
II 
transcriptome sequencing, potential toxin families are identified in the oral arms and tentacles 
included PLA2, lipases, CRiSPs, cystatins and serine protease inhibitors (Kunitz and Kazal 
peptides). This study reveals venom components of oral arms and tentacles of a blubber jellyfish for 
the first time and enhances our understanding of the mechanism of its sting. 
The fifth chapter describes the pharmacological profile of the hell’s fire anemone (Actinodendron 
sp.) venom. Due to the lack of transcriptome data available, an activity-guided fractionation 
approach (chromatography/tandem mass spectrometry/bioassays) is described to purify and 
characterise novel bioactives (toxins) with interesting pharmacological properties. The potential 
anemone toxin explained here (α3β2 nAChR blocker) is strong candidate as a lead compound for 
the development of diagnostic and therapeutic. 
Taken together, this thesis unravels the molecular evolutionary history of cnidarian toxin families, 
details a novel venom extraction technique which may transform cnidarian venom research, and 
also illustrates how proteomics, transcriptome sequencing and activity-guided fractionation can be 
used to discover new proteins and peptide toxins that can be bioactive resources for drug discovery 
and development.   
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Abstract 
Cnidarians are the oldest extant lineage of venomous animals. Despite their simple anatomy, they 
are capable of subduing or repelling prey and predator species that are far more complex and 
recently evolved. Utilising specialized penetrating nematocysts, cnidarians inject the nematocyst 
content or venom that initiates toxic and immunological reactions in the envenomated organism. 
These venoms contain enzymes, potent pore forming toxins, and neurotoxins. Enzymes include 
lipolytic and proteolytic proteins that catabolise prey tissues. Cnidarian pore forming toxins self-
assemble to form robust membrane pores that can cause cell death via osmotic lysis. Neurotoxins 
exhibit rapid ion channel specific activities. In addition, certain cnidarian venoms contain or induce 
the release of host vasodilatory biogenic amines such as serotonin, histamine, bunodosine and 
caissarone accelerating the pathogenic effects of other venom enzymes and porins. The cnidarian 
attacking/defending mechanism is fast and efficient, and massive envenomation of humans may 
result in death, in some cases within a few minutes to an hour after sting. The complexity of venom 
components represents a unique therapeutic challenge and probably reflects the ancient 
evolutionary history of the cnidarian venom system. Thus, they are invaluable as a therapeutic 
target for sting treatment or as lead compounds for drug design. 
Keywords 
cnidarians, venom, enzymes, pore forming toxins, neurotoxins, vasodilatory biogenic amines, 
human envenomation 
1.1 Introduction 
The phylum Cnidaria (corals, sea pens, sea anemones, jellyfish and hydroids) includes about 10,000 
species living in aquatic habitats worldwide [1]. They range in size from the tiny Hydra spp., at less 
than 1 cm in length, to the massive lion’s mane jellyfish, Cyanea capillata with the bell diameter 
exceeding 2 m [2]. The envenomation hazard to humans also varies widely from non-hazardous to 
the infamous Chironex fleckeri (Australian box jellyfish), one of the most venomous animal 
dangerous to humans, as a meter of tentacle contact can provoke immediate cardiovascular collapse 
and death even within minutes after a sting [3]. The majority of cnidarians live in salt water habitats 
at different water depths. However, approximately 40 species, mostly hydrozoans [4] live in 
freshwater. Cnidarians are characteristically radially symmetrical [5], although they can also exhibit 
directional asymmetry or bilateral symmetry. For example, morphological studies on 
Siphonophores (class Hydrozoa) suggest that directional asymmetry has been gained and/or lost on 
multiple occasions [6], whilst most anthozoan polyps exhibit bilateral symmetry possessing two 
orthogonal  body axes [5].   
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Despite the variety in size, toxicity, habitat and morphology several cellular characters are common 
to the members of Cnidaria, such as two unicellular layers (ectoderm and endoderm) separated by 
an extra-cellular matrix (mesoglea), neuromuscular systems and multiple sensory systems [7, 8]. 
Molecular evidence and fossil data place the origin of cnidarians prior to the Ediacaran period ~ 750 
million years ago and major taxa diversification from the remaining metazoans prior to the 
Cambrian ~ 550 million years ago [9-11].  
Cnidaria is an ancient clade of animals with complex venom compositions. Since their venoms have 
been much less intensively studied compared to other venomous clades, cnidarian venoms serve a 
unique therapeutic challenge. For example box jellyfish still remain one of the most medically 
important cnidarian venoms worldwide with limited therapeutics on offer. Therefore 
transcriptomics and proteomics data for the identification and characterising of their venom 
components is rapidly accumulating in recent times [12-14]. 
1.2 Cnidarian Phylogeny 
Based upon mitochondrial DNA (mtDNA) data [15] and life cycles [8, 16] cnidarians are divided 
into two extant subphyla: Anthozoa and Medusozoa. Anthozoans possess circular mtDNA, similar 
to that of other metazoans while medusozoans have atypical linear mtDNA.  The members of 
medusozoan classes Hydrozoa, Schyphozoa, Cubozoa and Staurozoa display a triphasic life cycle in 
transition of generations: a free-swimming planula larva, a sessile polyp stage and sexual pelagic 
medusa stage. In anthozoans the medusa stage is lost and sessile adults represent the sexually 
propagating stage. The life cycle will be discussed in more details further in this review. 
1.3 Cnidarian Life Cycle 
There is significant morphological diversity in the cnidarian life cycle, as a single species may 
display a variety of forms whether it is sessile, polyp, tiny free-swimming planula larva or a pelagic 
medusoid. The life cycle of both medusozoans and anthozoans comprises sexual reproduction and 
an asexually budding phase. In medusozoans, the adult medusa is either male or female, and the 
fertilized egg (zygote) is retained inside the female’s gastric cavity [17, 18]. However, in 
anthozoans, the polyp colonies may be single sex [19] or both male and female [20]. In general, the 
asexual life cycle of medusozoans includes a fertilized egg, which forms tiny pelagic planula larva 
that settles down to the sea floor and form a sessile polyp. These polyps further develop a hydroid 
polyp colony, which liberates medusae by budding from the trunk [18]. Amongst the medusozoans, 
hydrozoans have the greatest variation in life cycle. For example, species in the Campanulariidae 
family lack the medusa stage [21] and the members of the order Trachymedusae never form polyps 
[16]. The asexual life cycle of anthozoans is straightforward including four main stages: the 
fertilized egg, planula larvae, polyp and sessile sea anemone [16, 22]. 
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1.4 Cnidarian Venom Delivery System 
Cnidae are the defining subcellular specialisation of the phylum Cnidaria. They are specialized 
cellular structures capable of explosive discharge upon activation of cnidocytes (Figure 1-1). 
Cnidae contain elaborate structural elements and complex mixtures of bioactive compounds or 
venom for entrapping, subduing and digesting prey as well as deterring and repelling predators and 
competitors [23]. Cnidae are distributed in various parts of the cnidarian body and are classified into 
three major types: penetrant nematocysts, the volvent spirocyst and the glutinant ptychocysts. 
Cnidae comprise an eversible hollow tubule that is coiled and sometime spine laden. These phylum-
specific organelles are synthesized in specialised precursor cells called cnidoblasts. Following their 
secretion from the Golgi apparatus, the cnidae undergo further structural modifications in the 
extracellular matrix before migrating to the tentacle surface [24-26]. 
Penetrant nematocysts inject venom into the target organism and are the most studied class of 
cnidae. Penetrant nematocysts are found in all cnidarians and are morphologically and functionally 
the most diverse group of cnidae [27]. They are the primary weapon for capturing prey, repelling 
predators, and intra- and interspecies spatial competition [28]. Although nematocysts are mostly 
located on the tentacles, they also exist on the outer surface of the bell in certain species of the 
Alatinidae, and Carybdeidae families [29], oral arms of Catostylus mosaicus (Schyphozoa) [30] and 
the stomach (gastric cirri) of some cubozoans [29] probably helping to paralyse and digest the prey. 
Members of family Actiniidae also have nematocysts in the ring around the base of their tentacles, 
called acrorhagi, which they use for intra- and interspecific competition [31] and at filaments called 
acontia that are used for defence or paralysis of prey. 
Spirocysts are present in most anthozoans and may differ morphologically among different 
taxonomic groups [32].  The spirocyst capsule wall is thin and the everted tubule is helically folded.  
The tubule lacks spines, but contains adhering, hydroscopic substances that mechanically 
immobilize the prey [33]. Ptychocysts have been reported in tube-dwelling members of Actinaria 
and Ceriantharia. They create the protective tube in which species from these families live [33].  
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Figure  1-1. Overview of the cnidarian venom delivery system. (A) Schematic picture of a jellyfish; (B) 
Transverse section of a tentacle showing two epithelial cell layers, ectoderm (ec) and endoderm (en), divided 
by the mesoglea (m), various types of cnidocytes placed in nematocyst batteries (nb) and in the cells lining 
the tentacular lumen (tl); (C) Undischarged nematocyst. The nematocyst capsule contains a cocktail of 
toxins, shaft (sh), coiled-hollow tubule (t), barbs (b), and nucleus (n). The cnidocil (cn) acts as a 
mechanoreceptor that upon activation stimulates the discharge mechanism; (D) Discharged nematocyst. 
Epidermis (ep), dermis (d), subcutaneous tissue (sct), artery (a), nerve (n). Toxin mixture is injected into the 
prey’s skin and subcutaneous tissues (arrow). The figure was drawn according to the data in references [14, 
29, 34, 35].  
The mechanism of cnidae discharge in response to external stimuli (mechanical and chemical 
stimuli) is still not completely understood. The general osmotic/tension hypothesis proposes that the 
osmotic pressure of the intracapsular fluid temporary increases as a result of cnidae exposure to the 
external solution and subsequent exocytosis of cations from the capsule. The osmotic pressure 
differences across the capsule wall extant to the point that the pre-existing intracapsular pressure 
exceeds a critical threshold value and triggers the cnidae discharge [36-39]. The capsule content 
(venom) is located on the inner surface of the inverted tubule which, during discharge (tubule 
eversion-extension), everts such that the outside is now exposed and injected into the prey. The 
inside of the tubule remains contiguous with the inside of the capsule and the cnidae content or 
venom is then expelled down the axis of the hollow tubule [40].  
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The morphological properties of cnidae are taxonomically informative and may aid in 
distinguishing more distantly related species [33]. For instance, the presence of spirocyst is 
characteristic of some anthozoans [22]. In addition, the relative abundance of different types of 
nematocyst, along with variation in the body size in several populations may correlate to 
environmental factors, such as specific ecosystems, prey size and selectivity in prey capture. For 
example, C. fleckeri has a relatively large body and a higher ratio of mastigophores (the longest of 
the penetrant cnidae) correlating to the large organisms which they prey upon [41]. In addition to 
cnidae, venom of Cnidarians was shown to be also synthesized in other cell types such as 
ectodermal and endodermal gland cells and other, still unknown, cell types [42, 43].  
Table  1-1. Cnidarian venom composition.  
Toxin Type Found in Class Function MW (kDa) Reference 
Enzymes 
Phospholipase A2 
 
Anthozoa, Cubozoa, 
Schyphozoa, 
Hydrozoa 
Cytolytic, hemolytic, prey 
digestion 
13-45 [44-46] 
Metalloproteases 
Schyphozoa, 
Cubozoa, Anthozoa 
Cytotoxic, cytolytic, 
local tissue damage 
17-130 
[12, 14, 47, 
48] 
Pore forming toxins (cytolysins) 
Actinoporins and 
actinoporin-like 
proteins 
Anthozoa, Hydrozoa 
Cytolytic, hemolytic,  
cardiovascular and respiratory 
arrest 
20 [49-54] 
Jellyfish Toxins Cubozoa 
Hemolytic, cardiotoxic, 
cytolytic, myotoxic, 
cutaneous inflammation 
42-46 [13, 55-57] 
Hydralysins -
related toxins 
Hydrozoa, Anthozoa Cytolytic, prey digestion 27-31 [43, 58-60] 
Membrane Attack 
Complex-Perforin 
Anthozoa Cytolytic, hemolytic 60 [61, 62] 
Neurotoxins 
NaTxs (type I-III) Anthozoa 
Neurotoxic, cardiotoxic, 
insecticide 
3-8 [63-67] 
 
KTxs (type I,III 
and IV,V KTxs) 
 
 
Anthozoa 
 
Neurotoxic, hypotensive, 
cardiotoxic, analgesic, 
antimicrobial, 
immunosuppressive, 
anti obesity 
3-4 [68-75] 
Kunitz peptides 
(type II KTxs) 
Anthozoa 
 
Paralytic, serine protease 
inhibitor 
6 [76-79] 
Small Cysteine-
Rich Proteins 
(SCRiPs) and 
SCRiPs 
homologues 
Anthozoa Paralytic 4.3-5.8 [80] 
ASIC Inhibitors Anthozoa Analgesic 3 [81, 82] 
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TRPV1 Inhibitors Anthozoa Analgesic 3 [83, 84] 
Non-protein bioactive components 
Serotonin Hydrozoa, Anthozoa Vasodilation, sharp pain - [85] 
Histamine Anthozoa Vasodilation, sharp pain - [86, 87] 
Bunodosine Anthozoa Analgesic - [88] 
Caissarone Anthozoa Adenosine receptor antagonist - [89] 
1.5 Venom Composition 
Since the early 20th century, numerous analytical experiments and clinical observations have 
established the toxicological diversity of cnidarian venoms (Table 1-1). The diversity of venom 
components range from non-proteinaceous compounds (e.g. purines, biogenic amines) to high 
molecular weight proteins evolved over the course of hundred million years. Interestingly, some 
toxin family types identified previously in other venomous animals comprise the venom arsenal of 
cnidarians. The most striking example is Kunitz peptides which are expressed in sea anemones, 
cone snails, insects (proboscises and stingers), scorpions, spiders, snakes,  ticks and vampire bat 
(Desmodus rotundus) [90, 91]. Another example of convergent expression of toxins is potassium 
channel blocker Kv1 which not only evolved convergently in scorpions and sea anemones, but they 
even use the same residues for blocking the channel pores [92]. 
1.5.1 Enzymes 
1.5.1.1  Phospholipase A2 
Phospholipase A2 (PLA2) activity has been detected in the homogenized tentacles and acontia of 
cnidarians including subphylums Anthozoa, Schyphozoa, Hydrozoa and Cubozoa [44, 46, 93]. This 
enzyme hydrolyzes the sn-2 acyl bond of glycerophospholipids to produce fatty acids including 
arachidonic acid and lysophospholipid [22, 44]. It is commonly found in mammalian tissues where 
it plays important roles in vital body functions including dietary lipid catabolism, inflammation, 
signal transduction, and phospholipid remodelling [94].  However, the ubiquitous presence of PLA2 
across venomous animal lineages such as reptiles (snakes and anguimorph lizard), centipedes, 
insects (their bristles, proboscises, and stingers), arachnids (scorpions, spiders, and ticks), 
cnidarians, and cephalopods [44, 90, 95-98] may suggests the convergent recruitment of the body 
proteins into the toxic arsenal of animals. However, more study is needed to be conducted in order 
to specifically describe the evolution of PLA2s in venomous and non venomous clades. Toxic 
functions of PLA2 in cnidarian venoms have been proposed to include defence and immobilization 
and digestion of prey [44, 93]. Also, hemolytic activity was demonstrated in a PLA2 fraction 
recovered from acontial nematocysts of the sea anemone Aiptasia pallida [93]. Although PLA2 
enzymes are plentiful amongst cnidarians [44, 98], their molecular structure-function relationships 
remain to be elucidated. 
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1.5.1.2 Metalloproteases 
Metalloproteases are important venom components of terrestrial animals such as centipedes, snakes, 
and ticks [90, 99]. They induce haemorrhage and necrosis by degrading the extracellular matrix and 
preventing blood clot formation [90, 100]. These functions are commonly associated with several of 
the recurrent symptoms of sting such as skin damage, oedema, blister formation, myonecrosis and 
inflammation [100]. Metalloproteases were detected in the venom of jellyfish Stomolophus 
meleagris [12] and C. fleckeri [14]. A recent study focused on the enzymatic and cytotoxic 
functions of jellyfish metalloproteases and identified diverse proteolytic effects including 
gelatinolytic, caseinolytic, and fibrinolytic activities [47]. Zinc-dependent metalloproteases of the 
astacin family were detected in the soluble nematocyst content of the sea anemone Nematostella 
vectensis and were shown to be expressed in both gland cells and stinging cells. They originate 
from recruitment of the Bone Morphogenic Protein 1 (BMP1, also known as Tolloid) protein that 
plays a conserved role in animal development [48].      
1.5.2 Pore-Forming Toxins 
Pore forming toxins (PFTs) appear to be present in all cnidarian venoms. The mechanism of action 
of these toxins is penetration through the target cell membrane resulting in diffusion of small 
molecules and solutes leading to osmotic imbalance and cell lysis. PFTs exhibit dual structure i) a 
stable water-soluble structure that is monomeric and binds to the receptors on the target cell; (ii) 
membrane-bound structure consisting of oligomeric molecules that form integral membrane pores 
[101]. Cnidarian PFTs are classified in two groups based on the type of secondary structure they use 
to penetrate membrane upon pore-forming activity: α-PFTs which are a rich content of helices and 
form α-helical barrel structures, and β-PFTs that are rich in β-sheets and form β-barrel pores [101]. 
1.5.2.1 Actinoporins 
Actinporins are α-PFTs and are present in Anthozoa and Hydrozoa. They are basic proteins 
approximately 20 kDa in molecular size lacking in intramolecular disulfide bonds. Actinoporins 
mediate  various types of toxicity and bioactivity, such as cardiovascular and respiratory arrest in 
rats [50], lysis of chicken, goat, human and sheep erythrocytes [51, 53, 54] and cytotoxic effects 
[52], all caused by a pore-forming mechanism. Several studies have reported that actinoporins 
interact exclusively with sphingomyelin containing membranes [102-104], although sticholysin II 
from Stichodactyla helianthus binds to phosphatidylcholine membrane [105]. The mechanism of 
membrane penetration requires several steps: i) initial binding to the target membrane which is 
accomplished by an exposed aromatic-rich loop; (ii) lateral orientation and consequent 
oligomerization by a phosphocholine binding site; and (iii) insertion of the N-terminal amphiphilic 
α-helix segment to the lipid membrane [102, 103, 106]. High-resolution nuclear magnetic resonance 
9 
and Fourier transform infrared spectroscopy experiments [107], intrinsic fluorescence 
measurements [108], X-ray crystallography and electron microscopic analyses of two dimensional 
crystals [109] have suggested that, during the  membrane penetration, the N-terminal amphiphilic α-
helix segment of actinoporins detach from the main body and insert into the target membrane to 
produce pores with a diameter of 1–3 nm (∼11-30 Å) [54, 110]. 
1.5.2.2 Jellyfish Toxins (JFTs) 
Cubozoan-related porins are the most potent and rapid-acting toxins secreted by jellyfish species.  
This toxin family was originally reported in the cubozoan Carybdea alata as CAH1 [111], also 
reported as CaTX-A/B [112],  and subsequently identified in all cubozoans examined including 
CrTX-A/B from Carybdea rastoni [55], CqTX-A from Chiropsalmus quadrigatus [56], CfTX-1/2 
and CfTX-A/B/Bt from C. fleckeri [13, 113]. However, homologues of cubozoan porins were 
reported in Scyphozoa (Aurelia aurita), Hydrozoa (Hydra magnipapillata) [13], Anthozoa (Aiptasia 
pallida) and various hydroids (Hydractinia symbiolongicarpus and Hydra vulgaris), suggesting a 
common evolutionary origin of these toxins [80]. Characteristically, they are basic proteins with a 
molecular weight of 40 to 46 kDa and contain both α and β domains. The hypothetical mechanisms 
underlying pore formation involves oligomerization of several amphiphilic and hydrophobic α-
helices in the N-terminal region of the toxin resulting in distortion of the plasma membrane and cell 
death [13, 112, 113]. The similarity in the three-dimensional structure of the N-terminal domain of 
CfTX toxins to that of the α-pore-forming domain (domain I) of the insecticidal δ-endotoxins from 
Bacillus thuringiensis suggests how toxins of this family insert into membranes. This mechanism of 
membrane insertion seem to be sufficient to explain the well-defined 12 nm (inner) and 25nm 
(outer) diameter pores created in human erythrocytes by CfTX toxins [3].  
Interestingly, the members of this toxin family exhibit varying target specify towards various 
vertebrate tissue. A recent study on CfTX toxins showed that CfTX-1/2 caused cardiovascular 
collapse within 1 min in anesthetized rats exposed in vivo to the venom, whereas CfTX-A/B more 
potent in eliciting in vitro hemolytic activity [13]. Although these data suggest that the jellyfish 
toxin family has undergone functional diversification, more structural/functional data are needed to 
understand the molecular evolutionary histories that formed this diversification. 
1.5.2.3 Hydralysins-Related Toxins 
In addition to porins found in cnidarians, recent studies have described a novel β-PFT family 
secreted from the digestive endodermal cells of green hydra (Chlorohydra viridissima) [43, 58]. 
These non-nematocyst, body-derived toxins secreted during feeding are suggested to play a role in 
lysing prey tissues [59]. These toxins are not active on membrane phospholipids or carbohydrates, 
but rather bind to specific membrane receptors and form pores [58]. A recent study characterised 
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aerolysin, a hydralysin homologue, secreted from pharyngeal ectodermal cell of N. vectensis and 
suggested a role in prey disintegration [60].  
1.5.2.4 Membrane Attack Complex-Perforin 
This group of β-PFT toxins have been detected in the venoms extracted from the sea anemones 
Phyllodiscus semoni and Actinaria villosa. The toxins may be used in prey capture/predator defence 
[61, 62]. Membrane attack complex (MAC) proteins have been identified in the complement system 
produced by T-cells and NK cells. The proteins create a transmembrane pore into the target cell and 
initiate various apoptotic cell death pathways [114].  
1.5.3 Neurotoxins 
Cnidarian neurotoxins (voltage-gated ion channel toxins) are a group of low molecular weight 
peptides and are among the best characterised toxins in terms of the mechanism of action. They are 
produced by sea anemones and have a fundamental role in the venom to help these sessile animals 
to immobilize their prey rapidly and to defend against predators. Neurotoxins prolong the action 
potential of the excitable and non-excitable membranes in sensory neurons and cardiac and skeletal 
muscle cells [64, 115] via modifying the sodium channel gating [64, 116, 117] or blocking the 
potassium channel gating during the repolarisation stage [115]. This causes the cell to become 
hyperactive and to release massive amounts of neurotransmitter at synapses and neuromuscular 
junctions that can cause initial spastic stage followed by descending flaccid paralysis. Sea anemone 
voltage-gated ion channel toxins have been studied extensively because they are valuable 
bioresources to study the structure and function of sodium and potassium channels and also to be 
used for development of drugs [73, 74] and bioinsecticides [66, 67].  
Several cnidarian neurotoxin polypeptides exclusively block Vanilloid Receptor 1 (TRPV1) and 
acid-sensing ion channel 3 (ASIC3), which take part in initiation and transduction of pain and 
hyper-algesia. These peptides are thus promising tools for the development of novel pain reducers.  
1.5.3.1 Voltage-gated Sodium (Nav) Channel Toxins 
Voltage-gated sodium (Nav) channel toxins (NaTxs) are transmembrane complexes composed of 
several subunits. The highly conserved α-subunit consists of four homologous domains (D1-D4) 
each containing six hydrophobic transmembrane regions (S1-S6) [117]. Anthozoan NaTxs and 
several other groups of toxins from scorpion and spiders bind to site 3 (loop S3–S4 in D4) of the 
Nav channels [64, 118] resulting in considerable neurotransmitter release in synapses. One possible 
explanation underlying its toxicity is the electrostatic interaction between a cluster of basic amino 
acids on the toxin with acidic amino acids at site 3 [119] locking S4 segment in its inward position, 
thus inhibiting the conformational changes of the channel necessary for fast inactivation [117]. 
11 
These toxins are divided into three groups: (i) type I NaTx; and (ii) type II NaTxs exhibit extensive 
sequence similarity and share similar function. In addition to type I and II NaTxs there is an orphan 
NaTx clade, that exhibits only a partial homology to both type I and type II NaTxs and shows 
similar mechanism of action to those [120, 121]. Lastly, there are short (~30 amino acids long) 
peptides in sea anemone venom that exhibit a similar activity to the rest of NaTxs families despite 
lacking any shared sequence motifs with the rest of them [118]. These peptides form the type III 
family and exhibit very high selectivity towards arthropod sodium channels [122]. 
1.5.3.2 Voltage-gated Potassium (Kv) Channel Toxins and Kunitz peptides 
Sea anemone voltage-gated potassium (Kv) channel toxins (KTxs) are categorized in five groups 
based on their sequence similarity and binding affinity towards different Kv channel families [72]. 
Type I KTxs have a molecular weight of 4 kDa with three disulfide bridges. They inhibit the 
potassium current through channel Kv1. and Kv3. subfamilies and intermediate conductance 
calcium-activated potassium
 
channels [22].  Type II KTxs are Kunitz peptides with a molecular 
weight of 6 kDa that are cross-linked with three disulfide bridges and are remarkable in their dual 
function of activity. Usually they act against trypsin and chymotrypsin proteinases in order to 
inhibit the rapid degradation of the venom protease by endogenous enzymes of the animals 
themselves or of the prey [31, 78, 79]. Interestingly, several sea anemone Kunitz peptides possess 
both Kv blocking activity similar to dendrotoxin and protease inhibiting activity [76, 123]. For 
example, kalicludin 1-3 from A. sulcata binds competitively to Kv1.2 channels to paralyse the prey 
rapidly. Type III KTxs are 3-4 kDa peptides with three disulfide bridges that have evolved from 
NaTxs under the regime of positive selection [80]. They block a variety of distinct potassium ion 
channels such as Kv3. 4 channel belonging to the rapidly inactivating Kv channel [68] and hERG 
(the human Ether-à-go-go-Related Gene) [69, 75]. Interestingly, the influence of positive selection 
does not result in the complete loss of sodium ion channel blocking activity, where several type III 
KTxs target both hERG and acid-sensing ion channel 3 (ASIC3, H
+
-gated Nav channels) [75].  
Type IV are structurally new peptides from the sea anemone Stichodactyla haddoni  displaying crab 
paralysis activity and are cross-linked with two disulfide bridges [124].  Type V has been found in 
the sea anemone Bunodosoma caissarum and is cross-linked by four disulfide bridges. This novel 
peptide is active on Drosophila Shaker IR channels [72].  
1.5.3.3 Small Cysteine-Rich Peptides (SCRiPs) 
This newly discovered group of neurotoxins have been reported in the ectoderm of reef-building 
corals Acropora millepora and SCRiP homologs have been retrieved in sea anemones, Anemonia 
viridis and Metridium senile [80]. The injection of recombinantly expressed A. millepora SCRiPs in 
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zebrafish (Danio rerio) larvae resulted in severe paralysis, suggesting the first peptide neurotoxin 
family described from scleractinian corals [80].  
1.5.3.4 ASIC Inhibitors 
ASICs are sodium-selective acid-sensing ion channels (ASIC) expressed in peripheral neuronal 
system. They have been associated with acidic pain during pathological conditions such as 
inflammation and ischemia. Recently, a novel peptide π-AnmTX Ugr 9a-1 from the venom of the 
sea anemone Urticina grebelnyi [81] and  PhcrTx1 from Phymanthus crucifer [82] have been 
reported to target ASIC channels.  These peptides are cross-linked by two disulfide bridges and 
have no sequence homology to other sea anemone neurotoxin peptides. 
1.5.3.5 TRPV1 Inhibitors 
TRPV1s are non-selective cation channels expressed in mammalians peripheral and central 
neuronal systems. They initiate neuronal response during inflammation stimuli, which allow them 
to be regarded as one of the most important molecular triggers of pain stimuli. The first peptidic 
TRPV1 inhibitor isolated from sea anemone venom was τ-SHTX-Hcr2b (APHC1) from H. crispa 
[83]. Subsequently, two homologous peptides (τ-SHTX-Hcr2c (APHC2) and τ-SHTX-Hcr2d 
(APHC3) that target TRPV1 were isolated from the same species [84]. These novel neurotoxins are 
promising new models for designing a new generation of analgesic drugs. 
1.5.4 Non-Protein Bioactive Components 
In addition to the protein and peptide compounds mentioned above, a number of pharmacologically 
active low molecular weight compounds have been detected in cnidarian venoms. Large amounts of 
5-hydroxytryptamine (5-HT, serotonin) have been reported in the water where hydra was stimulated 
electrically [85]. This presumably nematocyst-derived substance causes instant pain in predators 
and thus may have a defensive role [85]. Also the vasodilatation enhanced by serotonin may 
potentiate the effect of other venom components [85]. Histamine has been detected in the 
homogenised tentacles of the sea anemones Anemonia viridis (previously known as Anemonia 
sulcata) and Actinia equina [86, 87] . Like serotonin, histamine produces sharp pain and increases 
vascular permeability. Although these compounds have not been directly detected in isolated 
nematocysts, it is likely that they are involved in cnidarian envenomation, and treatment of sting 
victims with antihistamines has been recommended to relieve the symptoms [125]. Bunodosine, an 
N-acylamino acid, was purified from the venom of the sea anemone Bunodosoma cangicum. This 
compound exhibits a potent analgesic activity by activation of serotonin receptors [88]. Caissarone 
is a quaternary purine derivative isolated from the sea anemone Bunodosoma caissarum by 
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extracting the whole animal in acetone. This marine product has a high antagonist activity towards 
guinea-pig ileum adenosine receptors which stimulate gut function [89].  
1.6 The Role of Cnidarians Venoms in Drug Discovery 
Toxic compounds isolated from Cnidaria have been viewed to produce several serious implications 
to human health due to their neurotoxicity, cytotoxicity and tissue damage. However, novel findings 
have demonstrated that their toxins might offer a tool to study cell physiology [126] and provide 
promising sources of pharmacological lead/active agents for therapy of human diseases.  
Palytoxin is a highly potent non-protein toxin isolated from order Zoantharia (soft corals) of the 
genus Palythoa and Zoanthus and the sea anemone Radianthus macrodactylus [127]. The 
interaction of palytoxin with Na
+
, K
+
-ATPase pump in almost every excitable tissue induces passive 
ion conductance which triggers K efflux, Na influx and massive membrane depolarization and 
tissue contraction [127, 128]. Palytoxin has been reported for anti-cancer activity against head and 
neck carcinoma cells [129], Ehrlich ascites tumour and P-388 lymphocytic leukaemia cells [130]. 
The mechanism of action of its cytotoxicity and tumour suppressor activity has been established by 
actin filament distortion and apoptosis [131]. Conversely, palytoxin has been identified as a tumour 
promoter by disrupting the regulation of cellular signalling cascades [132]. 
Over the past decade, several cytolysins and protease inhibitors have been extracted from the sea 
anemone A. equina. Equinatoxin II (EqT II) is a pore-forming protein that has been shown to have 
significant toxicity against  Ehrlich ascites tumour and L1210 leukaemia cell lines [133] and diploid 
lung fibroblasts of the Chinese hamster [134]. Equistatin is a potent inhibitor of papain-like cysteine 
proteinase and aspartic proteinase cathepsin D [135]. Overexpression and hypersecretion of 
cathepsin-D has been reported in  breast carcinoma cells [136], and papain-like cysteine proteases 
are involved in diseases of the central nervous system [137]. 
Recently antibutyrylcholinestrasic activity was detected in the crude venom extracted from the 
tentacle material of the Mediterranean jellyfish Pelagia noctiluca. Inhibition of butylcholinestrase 
in the central nervous system may prove useful in the treatment of neurodegenerative diseases such 
as Alzheimer’s disease and senile dementia [138]. 
ShK is a potent Kv1.3 channel blocker toxin that isolated from the sea anemone S. helianthus. Since 
this channel is crucial in the activation (proliferation and cytokine production) of human effector 
memory Tcells (TEM), ShK could provide a valuable immunosuppressant for the treatment of 
autoimmune diseases mediated by T cells [73]. Kv1.3 blockers are also considered as a therapeutic 
target for the treatment of obesity, thus highlighting the potential use of ShK in treatment of obesity 
and insulin resistance [74].   
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1.7 Envenomation 
Fortunately, due to the biophysical properties of the discharge event many cnidarians lack the 
capacity to penetrate human skin. Further, stings by most species with cnidae capable of perforating 
human tissue lead only to a negligible to moderate transient irritation/burning sensation. In contrast, 
contact with several jellyfish, sea anemone and coral species can cause severe pain, tissue damage 
and even cardiovascular collapse and death. The venom of the hazardous animals is introduced into 
the target tissue (epidermis, dermis, vasculature, lymphatic system and probably in some cases 
subcutaneous or muscular structures) (Figure 1-1) [125] and initiates immediate and delayed 
immunological and toxicological responses [139-141]. Envenomation symptoms are determined by 
the contents of the venom, the volume of the injection, the health of the patient and the duration of 
the tentacle-skin contact [125]. 
One of the most important steps in the treatment of human envenomation is to use specific fluids to  
prevent further nematocyst discharge, since physical attempts to detach remaining tentacles from 
the victim’s skin might cause massive discharge [34, 142]. Since 1908 numerous traditional 
remedies such as urea, seawater, vinegar, methylated spirits etc. have been used to inactivate the 
undischarged nematocysts on the adhered tentacles and/or to alleviate pain [14, 34, 143, 144]. These 
chemicals have been used to varying degrees of success, ranging from complete success in certain 
species to complete failure in others. For instance, while certain chemicals such as ethanol, or 5% 
acetic acid in distilled water, cause massive nematocyst discharge in Hydrozoa and Cubozoa species 
[14, 143, 144], some other such as a food grade vinegar was found to inactivate the penetrating 
nematocysts of C. fleckeri rapidly and completely [34].  
Avoidance and treatment of human envenomation by cnidarian species is an increasingly important 
objective within the broader scientific community. It also represents a collaborative aim of medical, 
pharmacological, toxicological and biological disciplines towards developing improved 
understanding of field ecologies as well as effective therapeutics to minimize pathogenic impact on 
bathers. It also can improve our understanding of the food web and biome dynamics of these 
ancient and intriguing animals.  
1.8 Conclusions  
Members of Cnidaria phylum are ancestral venomous Eumetazoan with a unique phylogeny. In 
spite of recent efforts to extract and characterise novel toxins from cnidarians, much more remains 
to be done to investigate their toxins and their potential as new sources of therapeutic substances. 
Of the approximately 10,000 cnidarian species in existence, only 156 toxins from 10 
pharmacological families have been defined. Potentially useful new toxicological information is 
gradually accumulating. One promising solution towards broadening the knowledge on cnidarian 
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toxins is to apply high throughput sequencing technologies to identify novel structural and 
pharmacological groups of toxins [145, 146]. Nevertheless, the enormous potential of cnidarian 
venoms for understanding the activity of different receptors and channels in health and disease 
conditions, as well as their use as sources of novel pharmaceutical lead compounds appears to offer 
endless possibilities for future scientific research. 
 
Aims 
The ultimate aim of this thesis is to provide the first comprehensive insight into the evolution, 
diversification and biodiscovery potentials of the oldest venomous animal lineage, Cnidaria. Here, a 
combination of approaches was applied to achieve the following goals: 
1) Use state-of-the-art molecular evolutionary assessments to explore the evolutionary origin and 
diversification of venom in this ancient clade of animals. 
2)  Develop a novel technique to extract venom from cnidarians to facilitate venom research. 
3) Determine the venom profiles of representative species from three classes of cnidarians, 
including Cubozoa, Scyphozoa and Anthozoa. This was done by using combinatorial 
transcriptome/proteome approach and activity-guided fractionation. 
4) Characterise novel toxins with interesting pharmacological activities to demonstrate under-
researched biodiversity potentials of cnidarian venoms.  
 
Together, the outcomes of this thesis contribute greatly to our understating of the evolutionary 
forces that shape cnidarian venoms as well as provide a roadmap for the exploration of novel drugs. 
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Evolution of an ancient venom: Recognition of a Novel Family of 
Cnidarian Toxins and the Common Evolutionary Origin of Sodium 
and Potassium Neurotoxins in Sea Anemone 
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Abstract 
Despite Cnidaria (sea anemones, corals, jellyfish, and hydroids) being the oldest venomous animal 
lineage, structure–function relationships, phyletic distributions, and the molecular evolutionary 
regimes of toxins encoded by these intriguing animals are poorly understood. Hence, we have 
comprehensively elucidated the phylogenetic and molecular evolutionary histories of 
pharmacologically characterised cnidarian toxin families, including peptide neurotoxins (voltage-
gated Na
+
 and K
+
 channel-targeting toxins: NaTxs and KTxs, respectively), pore-forming toxins 
(actinoporins, aerolysin-related toxins, and jellyfish toxins), and the newly discovered small 
cysteine-rich peptides (SCRiPs). We show that despite long evolutionary histories, most cnidarian 
toxins remain conserved under the strong influence of negative selection—a finding that is in 
striking contrast to the rapid evolution of toxin families in evolutionarily younger lineages, such as 
cone snails and advanced snakes. In contrast to the previous suggestions that implicated SCRiPs in 
the biomineralization process in corals, we demonstrate that they are potent neurotoxins that are 
likely involved in the envenoming function, and thus represent the first family of neurotoxins from 
corals. We also demonstrate the common evolutionary origin of type III KTxs and NaTxs in sea 
anemones. We show that type III KTxs have evolved from NaTxs under the regime of positive 
selection, and likely represent a unique evolutionary innovation of the Actinioidea lineage. We 
report a correlation between the accumulation of episodically adaptive sites and the emergence of 
novel pharmacological activities in this rapidly evolving neurotoxic clade. 
Key words  
Cnidaria, sodium channel toxins, potassium channel toxins, phylogeny, disulfide-rich toxins, 
positive selection. 
2.1 Introduction 
Venoms are among nature’s most complex cocktails that are characterised by a diversity of 
molecules, such as large proteins, small peptides, polyamines, and salts, which disrupt the 
physiology of prey animals upon injection [147]. Several gene families encoding venom 
components have been subjected to extensive duplication and have evolved under the influence of 
positive (diversifying) selection [148, 149]. The evolution of venom has been extensively studied in 
several venomous lineages that are of relatively younger evolutionary origin, such as advanced 
snakes (originated ~54 Ma) [150] and cone snails (originated ~33–50 Ma) [151, 152]. However, to 
date, the evolution and diversification of ancient venom systems, such as those of cnidarians, 
remains understudied.  
The phylum Cnidaria (sea anemones, corals, jellyfish, and hydroids) is composed of diploblastic 
predatory animals [153], where all members are venomous [154]. Cnidarians are typified by the 
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unique venom delivery apparatus called nematocyst (stinging organelle), which they employ to 
inject a cocktail of toxins into animals for predation and defence [27, 153, 155]. Molecular and 
fossil data place the origin of cnidarians in the Ediacaran Period, ~600 Ma [10, 156, 157], making 
them the oldest lineage of venomous animals and an ideal phylum to understand the origin and 
diversification of venom. Because certain cnidarians serve pivotal ecological roles (e.g., reef-
building corals) and are important model organisms in the field of evolutionary developmental 
biology (sea anemones and hydroids), genomic and transcriptomic data for several cnidarian species 
are rapidly accumulating in recent times [158-161]. Moreover, certain cnidarian animals, such as 
box jellyfishes (Cubozoa), produce some of the world’s most lethal venoms [140]. In this study, we 
have assessed the phylogenetic histories and the molecular evolutionary regimes of a diverse range 
of cnidarian toxin families, including 1) sodium channel modulators (NaTx: type I and type II 
families) [118, 162] potassium channel toxins (KTx: type I and type III families) [115]; 3) 
aerolysin-related pore-forming toxins (PFTs) [58, 60]; 4) actinoporin PFTs [163]; 5) the jellyfish 
toxins (JFTs) [13]; and 6) the newly discovered family of small cysteine-rich peptides (SCRiPs), 
which have been previously implicated in biomineralization in corals [164]. Our results unravel 
fascinating insights into the evolutionary origin and diversification of venom in this ancient clade of 
animals. 
2.2 Results 
Cnidarians secrete a diversity of toxin types to facilitate predation and defence. Here, we present the 
phylogenetic histories and the molecular evolutionary regimes of eight pharmacologically 
characterised cnidarian toxin types. 
2.2.1 Neurotoxins 
Neurotoxins rapidly immobilize prey animals and play an extremely important role in the venoms 
of certain cnidarians. They disrupt ion conductance through the modification or blocking of the 
voltage-gated sodium (Nav) and potassium (Kv) ion channels: NaTx and KTx, respectively. Among 
cnidarians, neurotoxins have only been retrieved from the venoms of sea anemones (class: 
Actiniaria). NaTxs are one of the best characterised cnidarian toxins [118, 162, 165] and are 
classified into three types (type I–III) based on the cysteine arrangement, overall structure, amino 
acid composition, and immunological cross reactivity [64, 118, 122]. The distinction between type I 
and type II NaTxs has been artificial, considering the similarity they share in structure and function. 
However, whether they resolve into distinct phylogenetic clades remains to be investigated. Hence, 
we have analysed type I and type II NaTxs together. Based on sequence identity, sequence length, 
number of disulfide bridges, and binding affinities toward various Kv ion channels [115, 124, 166], 
sea anemone KTxs have been classified into five types: type I–V [72]. Because type II KTxs cannot 
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be distinguished from their physiological homologs (nontoxic body proteins) in the absence of 
biochemical characterisation [31]), and because not enough nucleotides of type IV and V KTxs 
have been sequenced to date, we have only analysed KTxs of type I and type III families. It should 
be noted that the five KTx types are not homologous [72]. We investigated the nature of natural 
selection influencing the evolution of genes encoding various cnidarian toxin families using 
maximum-likelihood models [167] implemented in PAML (see Methods). The site model 8 (M8) 
computed omega () of 0.58 and 0.66 for NaTxs and type I KTxs, respectively, indicating a strong 
influence of negative selection on these toxin types, while highlighting the influence of positive 
selection on type III KTxs ( = 1.33) (Figure 2-1 and Table 2-1).  
 
Figure 2-1. Molecular evolution of cnidarian toxins. Three-dimensional models of various cnidarian 
toxins with their molecular surface coloured according to the evolutionary conservation of amino acids are 
presented here (see colour code). Positively selected/episodically adaptive sites are depicted in red. Omega 
values, the number of sites detected as positively selected (Model 8, PP ≥ 0.95, Bayes-Empirical Bayes 
approach) and episodically adaptive sites (MEME) are also provided for the respective toxin class. PDB 
codes: Actinoporin: 1IAZ; sea anemone aerolysin: 3C0N; Hydra aerolysin: 2ZTB; NaTx: 2SH1; KTx type I: 
1ROO; and KTx type III: 1BDS. 
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Table 2-1. Molecular evolution of cnidarian neurotoxins. 
 FUBAR
a
 MEME Sites
b
 PAML
c 
(M8) 
Type I and Type II NaTx 
 
ω > 1d : 0 
ω < 1e : 25 
8 
0 
0.58 
Type I KTx 
ω > 1d : 1 
ω < 1e: 16 
5 
1 
(0+1) 
0.66 
Type III KTx 
 
ω > 1d : 3 
ω < 1e : 15 
 
5 
6 
(2+4) 
1.33 
NOTE.  = mean dN/dS. 
a 
Fast Unconstrained Bayesian AppRoximation. 
b 
Sites detected as experiencing episodic diversifying selection (0.05 significance) by the MixedEffects 
Model Evolution (MEME). 
c 
Positively selected sites detected by the Bayes Empirical Bayes approach implemented inM8. Sites detected 
at 0.99 and 0.95 significance are indicated in the parenthesis. 
d 
Number of sites under pervasive diversifying selection at the posterior probability ≥ 0.9 (FUBAR). 
e Number of sites under pervasive purifying selection at the posterior probability ≥ 0.9 (FUBAR). 
The Bayes Empirical Bayes (BEB) approach implemented in M8 failed to identify positively selected sites in 
NaTx. However, M8 identified one and six positively selected sites in type I and type III KTxs, respectively 
(Figures 2-1 and 2-2, Table 2-1, and Supplementary Tables S1.1–S1.3, Supplementary Material online).  
21 
 
Figure 2-2. Sequence alignment of NaTx, KTx type I, and KTx type III. Positively selected/episodically 
adaptive (PS/Epi), structurally/functionally important, and extremely well-conserved (percent ID ≥ 90%) 
sites have been depicted. UniProt accession numbers and pharmacological names of sequences are as 
follows. NaTx: 1) P01528 Anemonia viridis (Av2); 2) P01532 Anthopleura elegantissima (ApC); 3) 
Q76CA3 Stichodactyla gigantean (Gigt II); 4) P86459 Bunodosoma cangicum (Bcg1a); 5) B1NWS1 
Nematostella vectensis (Nv1); and 6) P30785 Heteractis crispa (RTX-V). KTx type I: 1) Q0EAE5 Anemonia 
erythraea (Aer1a); 2) O16846 Heteractis magnifica (Hm1a); 3) E2S064 Cryptodendrum adhaesivum 
(Sm1a); 4) P29187 Stichodactyla helianthus (She1a); 5) P29186 Bunodosoma granuliferum (BcsTx1); and 
6) Q9TWG1 A. viridis (AsKS). KTx type III: 1) P61541 A. elegantissima (APETx1); 2) P61542 A. 
elegantissima (APETx2); 3) B3EWF9 A. elegantissima (APETx3); 4) P11494 A. viridis (BDS-1); 5) P59084 
A. viridis (BDS-2); 6) P69930 Antheopsis maculate (Am-2); and 7) P84919 B. caissarum (BcIV). 
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The mixed effects model of evolution (MEME) identified as many as eight sites evolving under the 
influence of episodic diversifying selection in NaTxs, while identifying three and five sites in type I 
and type III KTxs, respectively (Figure 2-2 and Table 2-1). These results indicate that certain 
regions in these neurotoxins have evolved rapidly under the episodic influence of adaptive 
selection. To understand the surface accessibility of positively selected and episodically 
diversifying sites, we computed the accessible surface area (ASA) ratio for all sites in the homology 
models of these neurotoxins. Our analyses revealed that all four episodically diversifying sites, with 
an ASA ratio in the range of 60–100 (ASA ≥ 50 is characteristic of surface-exposed sites) in the 
secreted region of NaTxs, were surface exposed (Supplementary Table S2, Supplementary Material 
online). Six of the 8 positively selected and episodically diversifying sites in the mature sequence of 
type III KTxs had an ASA ratio in the range of 51–100, while only a single site was found to be 
buried (ASA ≤ 20 indicates buried residues). The remaining site (ASA = 35) in this toxin type could 
not be assigned to buried/exposed category. Similarly, the single positively selected site in KTx 
type I was surface exposed (ASA = 100), while the lone diversifying site in the mature region of 
this toxin had its side chain exposed (ASA = 47; ASA value ranging between 40 and 50 is 
indicative of residues with surface accessible side chains). Several previously published KTx type 
III toxins were known to have a similar cysteine framework and activity as that of the sea anemone 
NaTxs [70, 168-170]. Hence, we analysed them together in this study to explore the possibility of a 
common evolutionary origin of the two toxin types. Midpoint rooted nucleotide Bayesian and 
maximum-likelihood phylogenetic trees placed type III KTxs in the same clade as type I NaTxs 
(Bayesian posterior probability [PP] 0.997; bootstrap support 734/1,000), suggesting a common 
evolutionary origin of these two toxin types (Figure 2-3 and Supplementary Figure S1, 
Supplementary Material online). Our phylogenetic analyses further resolved NaTxs into four 
distinct clades: 1) Type I NaTx (polyphyletic clades); 2) type II NaTxs; 3) the orphan NaTx clade (a 
unique clade of NaTxs that does not belong to either type I or type II NaTxs); and 4) a clade of Nv1 
toxins from Nematostella vectensis (Figure 2-3).  
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Figure 2-3. The common origin of NaTx and KTx type III. The phylogenetic tree of NaTx and KTx type 
III built using nucleotide sequences is presented here. Node support (Bayesian posterior probability/bootstrap 
replicate support) for the major clades and clade-specific omega values are also provided. 
Rooting the tree with toxin sequences from N. vectensis or Halcurias carlgreni, two basal sea 
anemone lineages (for sea anemone species phylogeny [171], see Supplementary Figure S2, 
Supplementary Material online), did not change the topology of the tree and supported the common 
origin of NaTx and KTx type III (supplementary Figure S1, Supplementary Material online). 
Because neurotoxins from N. vectensis (Nv1) and H. carlgreni (Halcurin) are characterised by 
domains similar to both type I and type II NaTxs, they have been previously suspected to be among 
the most basal sea anemone neurotoxins [172, 173].  Because phylogenetic analyses in this study 
resolved type I and type II NaTxs into distinct clades, we computed omega values for each of these 
clades independently. These analyses suggested that both type I and type II NaTxs have evolved 
under the influence of negative selection (Supplementary Tables S3.1 and S3.2, Supplementary 
Material online). 
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2.2.2 Pore-Forming Toxins 
2.2.2.1 Actinoporins  
Actinoporins are arguably the best studied PFTs secreted by Cnidaria [163]. They typically interact 
with their target sphingomyelin membrane (SM) to form oligomeric pores, which result in osmotic 
imbalance and cell death [102]. It was previously shown that the presence of the aromatic cluster, 
an array of basic residues, the phosphocholine (POC) binding site, and the N-terminal region 
containing an amphipathic  α-helix are essential for the recognition and binding to the SM 
membrane and the cytolytic activity of actinoporins [102, 103, 108]. Mapping the results of 
evolutionary selection analyses on the sequence alignment of actinoporins revealed the greater 
influence of negative selection on regions responsible for this cytolytic activity. Most sites 
implicated in pore-forming activity and the structural stability were found to have evolved under the 
influence of negative selection (Figure 2-4).  
 
Figure 2-4. Sequence alignment of actinoporins. Episodically adaptive, structurally/functionally important, 
and extremely well-conserved (percent ID ≥  90%) sites have been depicted. UniProt accession numbers and 
pharmacological names of sequences are as follows: 1) P61914 Actinia equina (EqTII); 2) C5NSL2 
Anthopleura asiatica (bp-1); 3) P61915 Actinia tenebrosa (Tenebrosin-C); 4) C9EIC7 Urticina crassicornis 
(Urticinatoxin); 5) Q9U6X1 Heteractis magnifica (HMg III); and 6) P07845 Stichodactyla helianthus 
(StnII). 
The Fast, Unconstrained Bayesian AppRoximation (FUBAR) analysis, which detects sites evolving 
via pervasive diversifying and purifying selection, identified 7/9 POC binding sites, 4/7 sites in the 
array of basic residues, 6/8 sites in the array of aromatic residues, and 3/22 residues of α-helix as 
constrained by pervasive negative selection pressure (PP ≥ 0.90) (Table 2-2). M8 computed  of 
0.39 for actinoporins, indicating a strong influence of negative selection on this toxin type, while 
the BEB approach implemented in this model failed to identify positively selected sites (Table 2-2). 
However, the MEME identified as many as 25 sites in actinoporins as evolving under the influence 
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of episodic diversifying selection (Figures 2-1 and 2-4, Table 2-2, and Supplementary Table S4.1, 
Supplementary Material online). 
Table 2-2. Molecular evolution of cnidarian pore-forming toxins and SCRiPs. 
 FUBAR
a
 MEME Sites
b
 PAML
c 
(M8) 
Actinoporins 
 
ω  > 1d : 0 
ω < 1e : 121 
25 
o 
0.39 
Sea Anemone Aerolysins 
 
ω > 1d : 0 
ω < 1e: 300 
41 
0 
0.27 
Hydralysins 
 
ω > 1d : 0 
ω < 1e : 120 
9 
0 
0.21 
JFTs 
ω > 1d : 0 
ω < 1e : 287 
17 
0 
0.39 
Coral SCRiPs 
ω > 1d : 0 
ω < 1e : 18 
7 
0 
0.72 
NOTE.   = mean dN/dS. 
a 
Fast Unconstrained Bayesian AppRoximation. 
b 
Sites detected as experiencing episodic diversifying selection (0.05 significance) by the MixedEffects 
Model Evolution (MEME). 
c 
Positively selected sites detected by the Bayes Empirical Bayes approach implemented in M8. Sites 
detected at 0.99 and 0.95 significance are indicated in the parenthesis. 
d 
Number of sites under pervasive diversifying selection at the posterior probability ≥ 0.9 (FUBAR). 
e 
Number of sites under pervasive purifying selection at the posterior probability ≥ 0.9 (FUBAR). 
2.2.3 Aerolysin-Related Toxins in Sea Anemones and Hydroids  
Aerolysin-related toxins are nonnematocystic paralytic toxins with α-pore-forming activity, secreted 
from the nonnematocystic digestive cells of various sea anemones and hydra species (hydralysins) 
[58, 60, 174]. Because hydralysins were found to be secreted by Hydra viridissima during feeding, 
they have been theorized to play a role in the digestion of prey animals (e.g., crustaceans) [59]. 
Hence, it has also been hypothesized that aerolysin-related toxin homologs in sea anemones, which 
are secreted by the ectodermal cells of the pharynx, play a similar role [60]. Interestingly, 
hydralysins and the sea anemone aerolysin-related toxins have been suggested to originate from two 
independent recruitment events that involved horizontal gene transfers [60]. Evolutionary 
assessments revealed that aerolysin-related toxins in both sea anemones and Hydra have evolved 
under the extreme influence of negative selection ( of 0.27 and 0.21, respectively) (Table 2-2 and 
Supplementary Tables S4.2 and S4.3, Supplementary Material online). FUBAR revealed numerous 
amino acid sites in these toxin types that evolved under the pervasive influence of negative 
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selection (300 and 120 sites, respectively). Although MEME detected only 9 sites as episodically 
adaptive in hydralysins, as many as 41 sites were detected in aerolysin-related homologs of sea 
anemones (Figures 2-1 and 2-5 and Table 2-2).  
 
Figure 2-5. Sequence alignment of hydralysins. Episodically adaptive, structurally/functionally important, 
and extremely well-conserved (percent ID ≥  90%) sites have been depicted here. UniProt accession numbers 
and pharmacological names of sequences are as follows: 1) Q86LR2 Hydra viridissima (Hln-1); 2) X2GKY3 
Lysinibacillus sp. (Hln-2); 3) Q52SK7 Hydra vulgaris (Hln); 4) Q564A5 H. viridissima (Hln-2); and 5) 
Q52SK6 H. viridissima (Hln-3). 
2.2.4 Jellyfish Toxins  
JFTs are among the most dangerous toxins secreted by jellyfish and are known for a diversity of 
immunological and toxicological activities, including hemolyticity, cardiotoxicity, cutaneous 
inflammation, and necrotic activities. It has been proposed that their pore-forming activity is 
responsible for toxicity associated with human envenomations [140]. Originally, JFTs were 
reported to be limited to Cubozoa and Schyphozoa. However, homologs of JFTs were recently 
reported in H. magnipapillata [13]. Through BLAST searches, we have retrieved such homologs 
from various sea anemones (Aiptasia pallida) and various hydroids (Hydractinia 
symbiolongicarpus and H. vulgaris), suggesting that JFTs originated within the common ancestor of 
all extant cnidarians more than 600 Ma.  of 0.39 was computed by M8 for JFTs, highlighting the 
significant influence of negative selection on this toxin type (Table 2-2, Supplementary Figure S3 
and Supplementary Table S4.4, Supplementary Material online). Although BEB failed to detect any 
site in this toxin as positively selected, MEME identified as many as 17 sites that evolved under 
episodic bursts of positive selection. 
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2.2.5 Small Cysteine-Rich Peptides 
SCRiPs were originally identified as genes unique to reef-building corals (Scleractinia) that are 
downregulated during heat stress [164]. Given the similarity in the temporal expression pattern they 
share with galaxin, a key protein involved in the biomineralization process [175], SCRiPs were 
implicated in calcification of the coral skeleton [164]. However, a greater sequence diversity in 
SCRiPs (Figure 2-6) is uncharacteristic of homeostatically important proteins, such as those 
involved in the biomineralization process. Previously, a α-defensin domain was reported in Mfav-
SCRiP1 [164] and InterPro [176] scanning performed in our study detected a domain that is very 
similar to the basic myotoxic domains of rattlesnake crotamine toxins (InterPro entry: IPR000881). 
Moreover, like SCRiPs, several peptide toxins in sea anemones have also been shown to exhibit 
downregulation in expression as a result of thermal stress [177]. Considering these observations, we 
suspected that SCRiPs may represent a class of toxins and not calcifying proteins as claimed by 
earlier studies. BLAST searches in this study surprisingly retrieved SCRiP homologs in sea 
anemones, Anemonia viridis and Metridium senile (Figure 2-6), refuting the claim that these 
peptides are specific to scleractinian corals [164]. To gain further understanding regarding the 
bioactivity of SCRiPs, we expressed Amil-SCRiP1, Amil-SCRiP2, and Amil-SCRiP3 from the 
scleractinian coral Acropora millepora in a recombinant form (see Methods). Although the 
expression of Amil-SCRiP1 was unsuccessful, Amil-SCRiP2 and Amil-SCRiP3 were expressed in 
relatively large amounts (1.5 mg protein per 1 l of bacterial culture). This enabled us to test the 
notion that the two peptides are toxic. Interestingly, the injection of these recombinantly expressed 
SCRiPs in blowfly larvae (Sarcophaga falculata) did not result in toxicity, while the incubation of 
zebrafish (Danio rerio) larvae at a concentration of 230 mg/ml resulted in severe neurotoxicity (data 
not shown). In the first few minutes of incubation with SCRiPs, the fish exhibited abnormal tail 
twitching. In contrast to the control group incubated with bovine serum albumin, fish incubated 
with SCRiPs gradually exhibited frequent twitching and shivering, stopped reacting to touch, and 
eventually became completely paralysed. All fish incubated with Amil-SCRiP2 died within 200 min 
of exposure, while Amil-Scrip3 killed fish within 16 h. These results support the notion that SCRiPs 
may serve as neurotoxins, making them the first peptide neurotoxin family described from 
scleractinian corals. M8 computed  of 0.72 and the BEB approach failed to identify positively 
selected sites in SCRiPs (Table 2-2, Figure 2-6, and Supplementary Table S4.5, Supplementary 
Material online). Thus, selection assessments indicated that coral SCRiPs have evolved under the 
influence of negative selection.  
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Figure 2-6. Sequence alignment of SCRiPs. Episodically adaptive, structurally/functionally important, and 
extremely well-conserved (percent ID ≥  90%) sites are depicted here. UniProt (sequences 1–5) and NCBI 
(sequences 6 and 7) accession numbers and pharmacological names of sequences are as follows: 1) C0H690 
Acropora millepora (SCRiP1); 2) C0H691 A. millepora (SCRiP2); 3) C0H692 A. millepora (SCRiP3); 4) 
C1KIZ0 Montastraea faveolata (SCRiP2); 5) C0H693 Montipora capitata (SCRiP1a); 6) FK725749 
Anemonia viridis; and 7) FC835414 Metridium senile. 
2.3 Discussion 
2.3.1 Strong Negative Selection Governs the Evolution of Most Cnidarian Toxins  
Molecular evolutionary assessments of cnidarian toxin families using the state-of-the-art methods 
revealed the extreme conservation of toxin-encoding sequences, despite their long evolutionary 
histories (Figures 2-1–2-6, Tables 2-1 and 2-2, and Supplementary Figure S3 and Supplementary 
Tables S1.1–S1.3, S3.1 and S3.2, S4.1–S4.5, Supplementary Material online). The computed  
values ranged between 0.21 and 0.72, indicating a strong influence of negative selection on a 
majority of sites in these proteins. This is in stark contrast to most predatory animal venoms that are 
known to rapidly evolve under the influence of positive selection [178-184]. Among all the 
cnidarian toxins examined in this study, only the type III KTxs seem to have evolved rapidly ( = 
1.33) under the influence of positive Darwinian selection. When the majority of lineages or sites 
evolve under the strong influence of negative selection, it becomes difficult to identify adaptive 
selection that occurs in short bursts and influences a small proportion of lineages or sites [185]. The 
application of MEME detected several sites (ranged from 5 to 41) in most toxin types that 
experienced episodic bursts of adaptive selection (Tables 2-1 and 2-2). Interestingly, a similar 
phenomenon was also reported in scorpions [186], which represent another ancient venomous 
animal lineage that originated nearly 400 Ma [187]. This reinforces the dynamic nature of venom in 
ancient lineages, where variations in venom-encoding genes accumulate episodically, possibly 
under an evolutionary chemical arms race scenario with their target sites in prey animals. When 
toxin sequences that increase the potency and efficacy of envenoming are generated, they get fixed 
in the population and experience purifying selection for long periods of time. In contrast, in 
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evolutionarily younger lineages, such as cone snails and advanced snakes, the rapid evolution of 
genes under the positive Darwinian selection is much more pronounced.  
2.3.2 Most Adaptive Sites in Cnidarian Neurotoxins Are Surface Accessible 
It has been suggested that most venom proteins that are involved in predation evolve through rapid 
accumulation of variation in the exposed residues (RAVER), where the molecular surface of the 
toxin accumulates bulk of the variations under the significant influence of positive Darwinian 
selection, while preserving the core residues involved in stability and/or catalytic activity [184]. As 
synthesis and secretion of proteins is an energetically expensive process, over time, mutations that 
lead to the loss of stable structure and function are filtered out of the population by purifying 
selection. Thus, favouring the conservation of structurally important and catalytic residues. 
Moreover, the accumulation of variations on the molecular surface of the toxin seems to be 
advantageous as the altered surface biochemistry might lead to neofunctionalization (generation of 
novel pharmacological properties) and assist in immunological evasion [91]. Computation of ASA 
ratios revealed that all four episodically diversifying sites in the mature peptide of NaTxs, one 
positively selected and another episodically adaptive site in KTx type I, were surface exposed 
(Supplementary Table S2, Supplementary Material online). Six of the eight positively selected and 
episodically diversifying sites in the mature sequence of type III KTxs were also surface exposed, 
while only one site was buried. Thus, a majority of positively selected or episodically adaptive sites 
in neurotoxins are surface exposed. RAVER has been reported in a myriad of animal lineages and 
in a plethora of venom proteins, including scorpion neurotoxins [91, 181, 182, 184, 188-191]. 
Hence, it appears that even the toxins of the most ancient animal lineages adopt RAVER and favour 
the accumulation of variations on the molecular surface. 
2.3.3 Negative Selection Constrains the Evolution of Pore-Forming Toxins 
It is particularly interesting to note that most of the cnidarian PFTs have evolved under the extreme 
influence of negative selection (Figures 2-2 and 2-4, Table 2, and Supplementary Figure S3 and 
Supplementary Tables S4.1–S4.5, Supplementary Material online). This may be a result of their 
ability to utilise certain amino acids (e.g., charged, polar, or hydrophobic) to non-specifically bind 
to the membranes of target cells in prey animals, before potentiating the deadly pore-forming 
activity. As a result of this nonspecific function, they probably do not experience the predator–prey 
chemical arms race and could act on a very wide range of species. Moreover, it becomes necessary 
to conserve a variety of residues on their molecular surface that are involved in binding to target 
cells (Figures 2-4 and 2-5). As outlined above, a majority of residues in actinoporins that are 
implicated in binding to target cells were found to have evolved under the pervasive influence of 
negative selection (Figure 2-4). Additionally, in order to gain their pore-forming function, 
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actinoporins oligomerize into complex tetramers via the interaction of several residues [192]. 
Consequently, to ensure the proper organization of these toxins into complex tertiary structures, 
structurally important residues evolve under the constraints of negative selection. A similar 
phenomenon has also been noted in certain classes of snake venom toxins that exhibit nonspecific 
cytotoxicity [184, 193], emphasizing the fact that not all toxins evolve rapidly. 
2.3.4 The Common Evolutionary Origin of Sodium and Type III Potassium Neurotoxins in 
Sea Anemones 
Bayesian and maximum-likelihood phylogenetic reconstructions in this study placed the type III 
KTxs in the same clade as type I NaTxs (Figure 2-3; Bayesian PP 0.997, bootstrap support 734/ 
1,000), suggesting a common evolutionary origin of these two types. Although both type I and type 
II NaTxs remained constrained under the influence of negative selection, type III KTxs were found 
to have evolved rapidly ( = 1.33; six positively selected sites). Polytomy was observed at the node 
that leads to NaTx type I and KTx type III clades, suggesting that these proteins likely underwent 
rapid radiation in a short time. The pharmacological diversity in this neurotoxic lineage is probably 
reflective of an adaptive radiation. The examination of various sea anemone transcriptomes 
(Edwardsioidea: N. vectensis [194] and Edwardsiella lineate [195]; Acuticulata: M. senile and A. 
pallid [196]) failed to retrieve type III KTxs from these lineages. Hence, type III KTxs probably 
represent a unique evolutionary innovation of actinioids, such as Anemonia, Bunodosoma, and 
Anthopleura (for sea anemone species phylogeny [171], see Supplementary Figure S3, 
Supplementary Material online). Thus, it is likely that a subset of sodium channel targeting toxins 
experienced episodic bursts of adaptive selection in Actinioidea and accumulated mutations at an 
elevated rate, resulting in the origination of a novel toxin type that can target potassium ion 
channels. Interestingly, several KTx type III toxins still retain the ability to modulate sodium ion 
channels in prey animals. Thus, the evolution of neurotoxins in sea anemones is fascinating, 
because a subtype of potassium ion channel targeting toxin evolved within the sodium ion channel 
targeting toxins, and the potassium channel toxins evolved on at least five independent occasions 
(type I–V KTxs). It is also interesting to note that Actinioidea, which is likely the only sea anemone 
superfamily to have rapidly evolving type III KTxs, include several species with highly potent 
venoms such as A. virids, Anthopleura elegantissima, and Anthopleura xanthogrammica  [197, 
198]. Thus, the evolution and diversification of several toxin types including type III KTxs, within 
Actinioidea, may have facilitated the emergence of a highly potent venom in this lineage. 
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2.3.5 Functional Diversification of Sea Anemone Neurotoxins 
It has been documented that a single point mutation can alter the biochemical activities of toxins. 
APETx3, a type III KTx from A. elegantissima, differs from its homolog APETx1, a selective toxin 
modulator of human ether-a-go-go related gene (hERG) voltage-gated potassium channels, only in 
having a threonine instead of proline at position 3 (position 4 in Figure 2-2). Fascinatingly, this 
single point mutation has been demonstrated to be responsible for the loss of APETx3’s ability to 
modulate hERG channels [170]. This change has also been correlated with the origination of a 
different biochemical activity: the ability to modulate voltage- gated sodium ion channels [170]. 
Strikingly, our evolutionary assessments detected this site as experiencing episodic influence of 
adaptive selection (Figure 2-2). Recently, several other sites were identified in APETx2 from A. 
elegantissima, as important for inhibiting hERG and the unrelated acid-sensing ion channel 3 
(ASIC3) [75]. Evolutionary analyses in this study identified many of these functionally important 
sites as episodically adaptive: 1) Sites 21 and 36 (important for ASIC3 inhibition) and 2) site 22 
(important for interacting with hERG; Figure 2-2). However, none of the positively selected sites 
we identified in type III KTxs coincide with sites in APETx2 that are responsible for targeting both 
hERG and ASIC3 channels [75]. Thus, positive selection has strongly shifted the pharmacological 
properties of the toxin between targets but does not result in the complete loss of activity, which 
could have a deleterious effect on the fitness of the animal. We also identified a few functionally 
important sites in other classes of neurotoxins and PFTs that experienced episodic adaptation 
(Figures 2-2–2-5): 1) Site 2 in NaTxs which was shown to be responsible for a moderate decrease in 
the binding affinity to insect Nav channels upon mutagenesis (V2A) [173]; 2) sites 54, 117, and 144 
in actinoporins that are responsible for binding to cell membranes; and 3) the site in hydralysins 
shown to result in slight reduction (2.5-fold) of paralytic and hemolytic activity upon mutation 
(G129E) [58]. Additionally, sites that were shown to have minor effects on toxicity were also found 
to be positively selected (e.g., sites 12 and 40 in NaTx; Figure 2-1; [173]. These findings suggest 
that sites that are relieved of purifying selection pressures and those responsible for toxicity 
constitute the evolutionary hotspots in cnidarian toxins, as long as mutations do not result in the 
complete loss of toxicity. Such sites may also promote changes in toxin selectivity and expand the 
range of molecular targets [199]. 
2.3.6 SCRiPs May Represent the First Neurotoxin Family from Corals 
Because SCRiPs cause profound neurotoxic effects in fish, it is most likely that they are employed 
as neurotoxins. Moreover, SCRiPs have been reported to be widely expressed in the ectoderm of A. 
millepora [200], which further support their likely role in prey envenomation, as ectoderm is chiefly 
lined by nematocysts and gland cells in anthozoans. In contrast to previous conclusions that SCRiPs 
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are unique innovations of scleractinian corals [164], the retrieval of SCRiP homologs from sea 
anemones in our study (Figure 2-6) indicates that these proteins evolved nearly 500 Ma in the 
common ancestor of sea anemones and scleractinian corals [160]. Because reef-building corals form 
habitats for numerous species of marine animals, the understanding of their ecology and the 
evolutionary diversification of proteins, such as toxins that affect their ecological interactions, are 
important. Although peptide toxins from other cnidarians, particularly sea anemones, are well 
studied, practically nothing is known about venom in corals. Hence, the discovery of a novel family 
of neurotoxic peptides in this lineage is fascinating and may prove to be an important step forward 
in the understanding of the evolution of venom in this lineage. To conclude, venom research in the 
past has chiefly focused on relatively evolutionarily younger animal lineages, such as the venoms of 
advanced snakes and cone snails. Our findings provide fascinating insights into the evolution of 
venom in Cnidaria: 1) The common origin of sodium channel toxins and a subtype of potassium 
channel toxins in sea anemones; 2) the discovery of the first neurotoxin family from corals; 3) 
identification of strong evolutionary constraints on most cnidarian toxin types, especially PFTs; and 
4) insights into the functional diversification of various toxin types. These results emphasize the 
importance of understanding the molecular evolution, diversification, and phylogenetic histories of 
venom components, particularly in the ancient venomous lineages. 
2.4 Materials and Methods 
2.4.1 Phylogenetic Analyses 
Translated nucleotide sequences were aligned using MUSCLE 3.8 [201]. Sequence alignments in 
FASTA format have been provided in the form of a zipped file (Supplementary File 1, 
Supplementary Material online). The best-fit model of nucleotide substitution and amino acid 
replacement for individual toxin data sets were determined according to the Akaike’s information 
criterion using jModeltest 2.1 [202] and Prottest 3.0 [203], respectively (Supplementary Table S5, 
Supplementary Material online). Model averaged parameter estimates of the proportion of invariant 
sites (pinvar) and the gamma shape parameter (α) were used for reconstruction of trees. Maximum-
likelihood and Bayesian phylogenetic analyses performed on the nucleotide data sets allowed the 
reconstruction of the molecular evolutionary histories of various cnidarian toxins. Bayesian 
inference implemented in MrBayes 3.2.3 [204] was used and a minimum of 15×10
6
 generations in 4 
chains were run, saving every 100th tree. The log-likelihood score of each saved tree was plotted 
against the number of generations to establish the point at which the log-likelihood scores reached 
their asymptote. After the completion of burn-in phase, posterior probabilities for clades were 
established by constructing a majority-rule consensus tree for all trees generated. The maximum- 
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likelihood trees were generated using PhyML 3.0 [205]. Node support was evaluated with 1,000 
bootstrapping replicates. 
2.4.2 Selection Analyses 
Maximum-likelihood models [167] implemented in Codeml of the PAML [206] were employed to 
assess the nature of natural selection on various cnidarian toxin families examined in this study. 
Site-specific models, which estimate positive selection statistically as a nonsynonymous to- 
synonymous nucleotide substitution rate ratio () significantly greater than 1, were employed. 
Because no a priori expectation exists, we compared likelihood values for three pairs of models 
with different assumed  distributions: M0 (constant  rates across all sites) versus M3 (allows  
to vary across sites within “n” discrete categories, n ≥ 3); M1a (a model of neutral evolution) where 
all sites are assumed to be either under negative ( < 1) or neutral selection ( = 1) versus M2a (a 
model of positive selection), which in addition to the site classes mentioned for M1a assumes a 
third category of sites; sites with  > 1 (positive selection) and M7 (β) versus M8 (β and ω) [197]. 
The results are considered significant only if the alternative models (M3, M2a, andM8 that allow 
sites with   > 1) show a better fit in the likelihood ratio test (LRT) relative to their null models 
(M0, M1a, and M7: Do not allow sites  > 1). LRT is estimated as twice the difference in 
maximum-likelihood values between nested models and compared with the 2 distribution with the 
appropriate degree of freedom—the difference in the number of parameters between the two 
models. The BEB approach [207] is employed to identify sites under positive selection by 
calculating the posterior probabilities that a particular site belongs to a given selection class 
(neutral, conserved, or highly variable). Sites with greater PP (≥ 95%) of belonging to the “ω > 1 
class” were inferred to be positively selected. FUBAR [208] implemented in HyPhy [209] was 
utilised to identify sites evolving under the influence of pervasive diversifying and purifying 
selection pressures. Additionally, MEME [185] was used to efficiently detect episodically 
diversifying sites. 
2.4.3 Structural Analyses 
Consurf webserver [210] was used to map the evolutionary variability of amino acids onto the 
crystal structures of various cnidarian toxins. Furthermore, we calculated the ASA or the solvent 
exposure of amino acid side chains using GETAREA [211], which uses the atom co-ordinates of the 
Protein Data Bank (PDB) file and indicates if a residue is buried or exposed to the surrounding 
medium by comparing the ratio between side chain ASA and the “random coil” values per residue. 
An amino acid with an ASA ratio of ≤ 20% is considered to be buried, while an amino acid with a 
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ratio of 50% or more is likely exposed to the surrounding medium. Pymol 1.3 [212] was used for 
visualizing three-dimensional structures. 
2.4.4 Cloning, Recombinant Expression, and Purification of Toxins 
Primers carrying NcoI and BamHI restriction sites and corresponding to the mature Amil-SCRiP1, 
2, and 3 were designed according to the available transcript sequences [164]. The primers were used 
in a polymerase chain reaction (94 °C for 2 min, 34 times [94 °C for 20 s, 55 °C for 20 s, 72 °C for 
30 s] and 72 °C for 5 min) with A. millepora complementary DNA made from mixed 
developmental stages (kindly provided by Drs D. Hayward and E. Ball, Australian National 
University, Canberra). The resulting PCR fragment was digested with NcoI and BamHI (New 
England Biolabs, USA) and cloned with T4 DNA Ligase (Takara, Japan) into a pET-32b vector 
(Novagen, USA) digested with the same enzymes. Toxins were expressed fused to thioredoxin in 
the Escherichia coli Rosettagami strain (DE3, pLys; Novagen). Toxins were released from their 
thioredoxin tag and purified on HisTrap and Resource RPC columns connected to an AKTA fast 
protein liquid chromatography machine (GE Healthcare) as previously described for the Av3 toxin 
[164]. 
2.4.5 Toxicity Assays 
Toxicity assays on blowfly and 3-days-old zebrafish larvae were performed as described before [42, 
164]. The zebrafish larvae were kindly provided by Dr Y Gothilf (Tel Aviv University). 
Supplementary Materials 
Supplementary Figures S1 and S2, Tables S1.1–S5, and file S1 are available at Molecular Biology 
and Evolution online. (http://mbe.oxfordjournals.org/content/32/6/1598/suppl/DC1).
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Abstract 
Cnidarian venom research has lagged behind other toxinological fields due to technical difficulties 
in recovery of the complex venom from the microscopic nematocysts. Here we report a newly 
developed rapid, repeatable and cost effective technique of venom preparation, using ethanol to 
induce nematocyst discharge and to recover venom contents in one step. Our model species was the 
Australian box jellyfish (Chironex fleckeri), which has a notable impact on public health. By 
utilising scanning electron microscopy and light microscopy, we examined nematocyst external 
morphology before and after ethanol treatment and verified nematocyst discharge. Further, to 
investigate nematocyst content or venom recovery, we utilised both top-down and bottom-up 
transcriptomics–proteomics approaches and compared the proteome profile of this new ethanol 
recovery based method to a previously reported high activity and recovery protocol, based upon 
density purified intact cnidae and pressure induced disruption. In addition to recovering previously 
characterised box jellyfish toxins, including CfTX-A/B and CfTX-1, we recovered putative 
metalloproteases and novel expression of a small serine protease inhibitor. This study not only 
reveals a much more complex toxin profile of Australian box jellyfish venom but also suggests that 
ethanol extraction method could augment future cnidarian venom proteomics research efforts. 
Keywords 
Chironex fleckeri; transcriptome; proteome; nematocyst; pressure induced disruption; ethanol 
induced discharge 
3.1 Introduction 
Stinging cells (cnidocytes) are distinctive of venomous marine animals of Cnidaria phylum. They 
contain microscopic organelles (cnidae) that discharge explosively, injecting a mixture of 
compounds into prey or potential predators [46, 213]. Upon contact with human skin or other 
surface (e.g., prey and predator), penetrant cnidae or nematocysts evert harpoon-like tubules laden 
with spines that act like hypodermic devices to inject venom (proteinaceous porins, neurotoxic 
peptides and bioactive lipids) [24, 28, 214]. Envenomation syndromes induced by cnidarian animals 
represent a therapeutic challenge especially to bathers, swimmers and surfers. Envenomation 
symptoms are painful hemorrhagic skin lesions, systemic reactions (e.g., direct effects on muscle 
and nerve tissue), long-term immunological responses, and occasionally fatalities due to Chironex 
fleckeri cardiovascular and pore-forming toxins [3, 125, 140, 215]. 
In recent years, cnidarian venoms have begun to be investigated as a potential source of novel 
bioactive therapeutic compounds [216-219]. However, in comparison with the vast number of 
studies conducted on the venoms of other venomous animals such as snakes, cone snails, spiders 
and scorpions, cnidarian venoms have received scant attention from toxinologists. The principal 
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technical impediment in cnidarian research is the fact that the venom does not exist in a large 
discrete gland as an aqueous mixture in milligram quantities but instead is distributed in 
microscopic individual nematocysts, each containing picogram of protein [3]. Venom analysis at the 
picogram scale presents challenges as cnidarian venom is a complex mixture of bioactive 
molecules, some of which are aqueous while others are lipidic [3, 140]. As a consequence, a 
modern proteomics approach based on high-throughput mass spectrometry analysis is ideal [220]. 
Previous venom preparation techniques have been based upon electrical discharge of nematocysts 
through human amnion [221], or homogenization [222] and pulverization or maceration [223] of 
whole frozen tentacles and saline or phosphate buffer wash. However, the venom recovered 
utilising these methods is in fact total tentacular extracts comprised of the contents of both 
nematocysts and other tentacle cell types. Current venom preparation techniques are based on 
mechanical rupture of the isolated nematocysts with mortar and pestle grinding [224], glass beads 
[225] and sonication [215, 226] in the presence of extraction solutions such as distilled water or 
saline. However, difficulties relating to equipment availability and contamination of the venom by 
structural components (e.g., nematocyst capsule-walls) are the major disadvantages of a mechanical 
disruption and solvent based extraction approach. Another approach has been developed in which 
density purified intact cnidae are disrupted using pressure followed by rapid centrifugation to 
harvest the contents without contaminating then with tentacular material or structural components 
[3]. This technique results in venom with very high specific activity and complexity but is a 
laborious process. 
Since certain chemicals such as ethanol, or 5% acetic acid in distilled water, cause massive cnidae 
discharge in some cnidarian species [34, 143, 144] (Hydrozoa and Cubozoa, respectively), in this 
study we utilised ethanol to obtain venom proteins and peptides from box jellyfish, C. fleckeri, 
because of its significant envenomation consequences and need of opportune therapeutic tools [3, 
140]. This study highlights the advantages of this new technique, which results in pure venom, free 
of contaminants from the tentacles or structural components of nematocysts. 
3.2 Results and Discussion 
The venom composition of C. fleckeri has previously been studied, although the methodological 
approaches used to obtain venom varied between authors [221-226]. Moreover, due to the lack of a 
transcriptomic database underpinning the annotation of the isolated proteins, proteomic approaches 
were unlikely to discover novel toxins unique to this species. Notably, when pulverization based 
approaches are used on purified nematocysts in combination with a solvent extraction, the 
recovered proteins include structural components of the nematocyst capsule rather than just intra-
capsular material. Even more concerning is that many venom preparations are in fact solvent 
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extracts of the whole tentacles, and thus contain all tentacular biomolecules soluble in the chosen 
solvent. In addition, many current venom obtaining techniques based upon mechanical disruption of 
nematocysts are time-consuming and expensive. Here we report a new venom recovery technique 
based on chemically induced discharge of nematocysts that maximizes and accelerates the 
identification of the toxic molecules comprised in jellyfish venom. Also in order to rule out that the 
identified proteins are produced by tentacular epithelial cells, (e.g., toxin Nv1 localized to 
ectodermal gland cells in the tentacles rather than nematocysts [42]), we have isolated nematocysts 
from C. fleckeri, disrupted them in vitro and analysed and compared the released protein mixture 
with identified proteins in our method. 
3.2.1 Microscopy Examination of Undischarged and Chemically Discharged Nematocysts 
Thus far, there have been differences in the reported nematocyst types and morphology of C. 
fleckeri cnidome. Despite this diversity in the results of studies conducted by various research 
groups [29, 35, 41, 224], the consensus is that the cnidome includes four types of nematocyst: (i) 
those that contain the lethal venom component (microbasic p-mastigophores); (ii) those that 
penetrate the prey’s skin or cuticle and ensnare it with hook-like structures in order to secure close 
contact with the tentacles (small and large tri-rhopaloids); (iii) adherent cnidae which adhere to the 
prey via a coiled shaft upon discharge (holotrichous isorhizas); and (iv) enigmatic spineless 
adhesive cnidae that secrete sticky fluid (atrichous isorhizas) [29, 35, 41, 224]. 
In this study the effectiveness of ethanol in inducing discharge discharge C. fleckeri nematocysts 
was proved by both light microscopy and scanning electron microscopy (SEM). Prior to immersion 
in ethanol, SEM examination of tentacles revealed undischarged nematocysts, which were 
categorized as rod-shaped atrichous isorhizas (Figures 3-1A and 3-2B), banana-form microbasic p-
mastigophores (Figures 3-1B and 3-2C), large oval p-rhopaloids (Figures 3-1C, E, and 3-2B) and 
small sub-spherical p-rhopaloids (Figures 3-1D and 3-2C). In order to achieve a better 
understanding of nematocyst orientation within the tissue and the morphological characteristics of 
the discharged and undischarged nematocysts, the histological samples of tentacles were examined 
using light microscopy (Figure 3-2). The transverse section of the tentacle clearly showed three 
groups of nematocyst batteries: top, intermediate and lower (Figures 3-2A, E); with nematocysts 
located at the tips of the batteries. Before chemical discharge, tubules were observed to be coiled 
and twisted inside the intact nematocyst capsule (Figures 3-2A–C). After discharge, the capsule 
remained intact, although the capsular components including shaft, tubule and venom were expelled 
(Figures 3-2D–F and 3-3A–C). Moreover, after immersion in ethanol, the tentacle surface was 
found to be densely packed with discharged nematocysts (Figure 3-3D), with a few nematocysts, 
mostly those placed in lower nematocyst batteries remain undischarged (Figure 3-2E). As 
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previously suggested [34], the “roofed-over” effect of the top nematocyst batteries likely prevents 
the less-prominent intermediate and inferior batteries from being exposed to ethanol. It should be 
mention that this new ethanol recovery based method demonstrated higher yield in term of the 
number of proteins identified. Therefore, it is reasonable to propose that this method is more 
effective in obtaining a good yield of venom, as compared to a previously reported high activity and 
recovery protocol. The effect of ethanol on nematocyst discharge in C. fleckeri is in line with what 
previously reported, showing that ethanol stimulates nematocyst discharge of various species of 
jellyfish [34, 143, 144]. On the other hand, our observation differs from the inhibitory effect of 
ethanol on chemoactivation of in situ discharge in Pelagia noctiluca (Cnidaria, Scyphozoa) oral 
arms [142]. This inconsistency is probably due to specimens’ difference. 
 
Figure 3-1. Scanning electron microscopy (SEM) of undischarged C. fleckeri nematocysts.  
(A) Undischarged rod-shaped atrichous isorhiza; (B) banana-form microbasic p-mastigophore; (C) Large 
oval p-rhopaloid; (D) Small sub-spherical p-rhopaloid; (E) Detail of operculum (the door of the capsule) of 
an oval p-rhopaloid. The operculum (solid arrows) is found to be a convex shape, which upon discharge, part 
and permit the tubule and capsule components to be released. Scale bars, A, D, E 1 μm; B, C 10 μm. 
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Figure 3-2. Light microscopy (LM) of C. fleckeri nematocysts histochemically stained with Masson’s 
Trichrome. (A) The orientation of undischarged nematocysts in longitudinal section showing top batteries 
(TB), intermediate batteries (IB) and lower batteries (LB); (B) Undischarged large oval p-rhopaloid (black 
arrowhead) and atrichous isorhiza (white arrow); (C) Undischarged microbasic p-mastigophores (white 
arrowhead) and small sub-spherical p-rhopaloid (black arrow); (D) Discharged tentacular axis region 
showing gastrovascular cavity (GC), mesoglea (M), and epidermis (E); (E) Detail of epidermis evagination 
with ethanol discharged nematocysts. Note the nematocyst batteries; (F) Part of the epidermis showing the 
extruded tubules (black arrow). Note the empty capsule (black arrowhead). Scale bars, A, D, E, F 100 μm; B, 
C 50 μm. 
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Figure 3-3. Scanning electron microscopy (SEM) of ethanol discharged C. fleckeri nematocysts. (A)      
A discharged microbasic p-mastigophore (white arrowhead) with the extrude shaft (black arrow) and an 
atrichous isorhiza (white arrow); (B) Small sub-spherical p-rhopaloid. Note the operculum (white arrow); 
(C) High magnification SEM of shafts and tubules of microbasic p-mastigophores. Note the spines (white 
arrow); (D) Sublimed surface of a discharged tentacle. Scale bars, 10 μm. 
3.2.2 Transcriptome Assembly and Functional Annotation 
A total of 2,973,873 reads were obtained for the C. fleckeri tentacle transcriptome. Automated 
assembly resulted in 5128 contigs (Table S1). To classify the putative function of the resulting 
contigs we annotated them using BLAST2GO—from a total of 5128 contigs, 59.7% of them were 
successfully identified by BLAST annotation and we subsequently classified these contigs 
according to biological process, cellular component and molecular function, respectively. A 
complete description of the contigs, BLAST statistics, contigs classification and top-hit species can 
be found in Table S1.  
3.2.3 Comparative Proteomic Analyses and Identified Proteins 
ProteinPilot analysis of the C. fleckeri pressure disrupted nematocysts (PDN) proteome retrieved 
175 proteins (with 99% high-confidence spectra and a 1% FDR), representing 3.41% of the 
translated amino acid sequences sourced from the tentacle transcriptome (Table S2). The same 
approach applied to the chemically discharged nematocysts (CDN) proteome resulted in the 
identification of 241 proteins (with 99% high-confidence spectra and a 1% FDR), representing 
4.69% of the sequences found in the transcriptome (Table S3). Further gene ontology analyses by 
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BLAST2GO software classified the two sets of proteomes into 10, 18 and 13 categories according 
to their cellular component, biological process, and molecular function, respectively (Figure S1). 
On comparing the proteomic data retrieved from PDN and CDN, 129 of 175 PDN proteins were 
found in the CDN set (73.71%). On the other hand, from 241 of the proteins identified in the CDN 
proteome, 134 proteins (55.60%) were identified in the PDN proteome. The identified proteins from 
each of these samples are summarized and displayed in Table S4. 
Through our combined proteomic and transcriptomic approach, we identified newly described C. 
fleckeri haemolysin toxins CfTX-A (UniProt: T1PRE3) and CfTX-B (UniProt: T1PQV6) and 
potent cardiotoxic toxin CfTX-1 (UniProt: A7L035) [13] in venom obtained from both PDN and 
CDN. Interestingly, the CfTX-2 (UniProt: A7L036) gene identified in our tentacle transcriptome 
was only identified in the CDN venom sample—where it exhibited high proteomic coverage 
(42.39%)—and was completely absent from PDN venom sample. This pattern was observed with 
other protein types, as our chemical discharge approach resulted in a larger number of protein 
identifications and higher confidence values for the identified proteins (Table 3-1).  
We detected several metalloproteases containing ShK and astacin domains in the proteome of PDN 
and CDN that have not been previously identified in C. fleckeri venom. The ShK-containing 
metalloproteases have recently been characterised in mammalian proteomes where they display 
remarkable sequence similarity to BgK and ShK toxins from sea anemones [227]. Although two of 
the identified metalloproteases containing the ShK domain do not exhibit sequence homology to 
ShK and BgK toxins from sea anemones, suggesting that they do not possess potassium channel 
blocker activity. In addition to ShK domain, we found astacin domains (metalloprotease M12A 
family) in the metalloproteases of the C. fleckeri venom. The metalloprotease M12A family has 
been recruited into the venom systems of numerous animals, including the spider Loxosceles 
intermedia [228], centipedes [99], and the jellyfish Stomolophus meleagris [12]. These proteins are 
thought to be responsible for degrading the extracellular matrix, thereby facilitating the diffusion of 
other venom components to their molecular targets. Their presence in the nematocysts of the sea 
anemone Nematostella vectensis has been associated with defence rather than prey capture [48]. 
Although transcripts encoding proteases containing M12A and ShK domains were found in both 
PDN and CDN venoms here, their evolutionary history and present function in C. fleckeri venom 
remain unclear. However, given the additional experimental evidence of the presence of 
metalloproteases in cnidarian nematocyst venoms [12, 48], it is probable that C. fleckeri 
metalloproteases play a role in prey capture, prey digestion or defence (or a combination thereof). A 
plesiotypic serine protease-inhibitor (kazal-type) was found in the CDN sample. Recently, kazal-
containing transcripts have been found in the sea cucumber Holothuria glaberrima where they are 
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associated with a defensive/immunity role in the inactivation of bacterial proteases [229]. The 
possible role of this toxin in C. fleckeri venom remains unknown. 
Table 3-1 Summary of venom proteins/peptides identified from C. fleckeri venom material. 
Protein ID 
transcriptome 
match 
UniProt Accession 
#(s)/Best  Cnidaria 
BLAST Hit 
Conserved 
Domain 
Comparative 
Protein-level
a
 
%Cov (95%)
b
 #Matched 
peptides 
(%95)
c
 
  PDN CDN PDN CDN PDN CDN 
Known Cubozoa Toxins 
T0179 T1PQV6/Toxin B 
precursor 
_ 44 6 65.11 60.15 8 63 
T0362 T1PRE3/Toxin A 
precursor 
_ 25 7 29.7 55.3 12 49 
T2746 A7L035/Toxin CfTX-1 
precursor 
_ 93 40 45.9 77.9 3 14 
T2621 A7L036/Toxin CfTX-2 
precursor 
_ Not 
found 
68 Not 
found 
42.4 Not 
found 
10 
Metalloproteases 
T0344 A7S336; 
Predicted protein; 
Nematostella vectensis 
ShKT domain 
(IPR003582) 
47 27 16.92 23.69 6 27 
T0690 A7SNJ4; 
Metalloendopeptidase; 
Nematostella vectensis 
Peptidase 
M12A, astacin 
domain 
(IPR001506); 
ShKT domain 
(IPR003582) 
72 61 17.49 45.73 4 16 
T2821 A7S5S4; 
Metalloendopeptidase; 
Nematostella vectensis 
Peptidase 
M12A, astacin 
domain 
(IPR001506); 
177 77 25 47.5 2 12 
T1091 _ Peptidase 
M12A, astacin 
domain 
(IPR001506); 
207 189 12.7 7.7 1 2 
T2460 A7T0S0; 
Metalloendopeptidase; 
Nematostella vectensis 
Peptidase 
M12A, astacin 
domain 
(IPR001506); 
138 200 25.6 41 3 7 
Serine Protease Inhibitors 
T0134 A7SCV8;  
Predicted protein;  
Nematostella vectensis 
Kazal domain 
(IPR002350) 
Not 
found 
149 Not 
found 
5.34 Not 
found 
3 
NOTE. Pressure disrupted nematocysts (PDN); Chemically discharged nematocysts (CDN); 
a 
Comparative protein-level results across multiple searches using ProteinPilot 
b 
The percentage of matching amino acids from identified peptides having confidence greater than or equal to 
95% 
 
c 
The number of distinct peptides having at least 95% confidence. 
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3.3 Experimental Section 
3.3.1 Specimen Collection 
Mature live specimens of C. fleckeri were collected by dip net from Weipa, Queensland, Australia 
during the spring 2013 by Bryan Fry and Nicholas Casewell. For transcriptome analysis, fresh 
tentacles were dissected out manually then immediately frozen in liquid nitrogen and subsequently 
stored at -80 °C. For histology and Cryo-SEM studies, samples of tissue were dissected from the 
tips of both untreated and ethanol-treated tentacles, and then fixed in 10% neutral-buffered formalin 
(NBF) at pH 7.2. 
3.3.2 Nematocyst Morphology 
3.3.2.1 Cryo-Scanning Electron Microscopy  
Longitudinal and transverse sections (< 4 mm long) of the untreated and ethanol-treated tentacles 
that had previously been fixed in NBF were washed in phosphate buffered saline (PBS) at pH 7.2 
for 5 × 10 min then transferred to glutaraldehyde solution (3% in phosphate buffer, pH 7.2) for 
permanent preservation. Samples were frozen and examined with a Gatan Alto 2500 cryo-system on 
a JEOL JSM-7100F field emission scanning electron microscope (JEOL Ltd., Tokyo, Japan). 
Separately, untreated and ethanol-treated sections (3 × 5 × 2 mm: height, length and width) were 
placed in a metal flange-sample holder, locked into position and immediately frozen by immersing 
in liquid nitrogen. The samples were transferred into the cryo-system, and the tissue was either 
fractured with a blade (undischarged samples) or left intact (discharged samples). Subsequently, the 
water was removed from the surface region by raising the temperature to -80 °C for 20, 15 or 7 min, 
depending on the desired extent of sublimation of the ice. The sample was then coated with 
platinum to 5–7 nm and viewed at 2 kV. Images were stored digitally without modification except 
for adjustment of contrast and brightness. Cryo-fixation rapidly freezes the water component in a 
sample to form ice through heat exchange with the liquid nitrogen slush, producing a solid sample 
that can be fractured or viewed whole. The sublimation step avoids damage to the delicate, hydrated 
tissue caused by chemical drying and allows 3D visualization of structures within that tissue. 
3.3.2.2 Histology 
Ultra-structural analysis of the tentacles was carried out using histological sections of intact tentacle 
tips. Before processing, NBF fixed specimens were washed in PBS (pH 7.2) for 5 × 10 min to 
remove the fixative. The samples were then dehydrated in an ethanol series (70% × 45 min, 90% × 
45 min, 100% × 45 min), followed by paraffin wax embedding (2 × 45 min). Serial transverse 
sections, 6 μm in thickness, were taken at intervals along the length of the tentacles using a Hyrax 
M25 Rotary Microtome (Carl Zeiss, Jena, Germany). The sections were then stained with Masson’s 
Trichrome stain which gives clear distinction between collagen fibre, cytoplasm and nucleus [230]. 
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The slides were then observed by differential interference contrast microscopy (10–100 × 
magnification). 
3.3.3 Transcriptome Library Construction 
Chironex fleckeri tentacles were preserved in liquid nitrogen prior to use. Total RNA was isolated 
from 800 mg of frozen tentacle using the standard TRIzol Plus RNA purification kit (Life 
Technologies, Carlsbad, CA, USA). RNA quality was assessed using a Bioanalyser (Agilent, Santa 
Clara, CA, USA) and ribosomal RNA removed using the Ribo-Zero rRNA Removal Kit for 
Human/Mouse/Rat (Epicenter, Madison, WI, USA). The RNA-Seq library was prepared from 50 ng 
of the enriched RNA material using the ScriptSeq v2 RNA-Seq Library Preparation Kit (epicentre), 
following 12 cycles of amplification. The sequencing library was purified using AMPure XP beads 
(Agencourt, Brea, CA, USA), quantified using the Qubit dsDNA HS Assay Kit (Life Technologies) 
and the size distribution assessed using a Bioanalyser (Agilent). The library was sequenced on a 
single lane of an Illumina MiSeq machine housed at the Centre for Genomic Research, Liverpool, 
UK, generating 2,973,873 reads representing 1,481,186 read pairs. The ensuing read data was 
quality processed, first by removing the presence of any adapter sequences using Cutadapt 
(https://code.google.com/p/cutadapt/) and then by trimming low quality bases using Sickle 
(https://github.com/najoshi/sickle). Reads were trimmed if bases at the 3' end matched the adapter 
sequence for 3 bp or more, and further trimmed with a minimum window quality score of 20. After 
trimming, reads shorter than 10 bp were removed. Paired-end read data was assembled into 5128 
contigs using the de-novo transcriptome assembler VTBuilder [231] executed with the following 
parameters: min. transcript length 150 bp; min. read length 150 bp; min. isoform similarity 96%. 
Assembled contigs were annotated with the BLAST2GO Pro v3 [232, 233] using the BLASTX 
algorithm with a significance threshold of 1e-3, to provide BLAST annotations against NCBI’s non 
redundant (NR) protein database release 67 followed by mapping to gene ontology terms, and 
InterPro domain annotation using default parameters. Some sequences annotated ambiguously were 
confirmed using Expasy (UniProt Knowledgebase (Swiss-Prot + TrEMBL), Uniref100) 
comparison. Additionally, sequences identified proteomically were scanned for the presence of 
signal peptide with SignalP 4.1 Server [234], and checked for functional domains and gene 
ontology (GO) with InterPro [235] and the Conserved domain Architecture Retrieval Tool. Contigs 
were then translated using CLC Genomics Workbench 5 (CLC bio, Aarhus, Denmark) to provide 
all 6 reading frames to provide a sequence database for the proteomic characterisation of the venom 
components. Trimmed raw sequencing reads have been deposited in the SRA database of NCBI 
(http://www.ncbi.nlm.nih.gov/sra) with the BioProject identifier PRJNA273442. Assembled contigs 
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can be found in Supplementary File 1 and BLAST2GO annotation files are available by request 
from the corresponding author. 
3.3.4 Venom Extraction 
3.3.4.1 Chemically Induced Discharge of Nematocysts by Ethanol  
In order to induce chemical discharge of nematocysts, fresh live tentacles of a mature specimen 
were immersed in 1 litre absolute ethanol for 30 s at room temperature. The tentacle was then 
removed and the ethanol transferred to -80 °C to precipitate the proteins. After 24 h of precipitation, 
the material was centrifuged at 14,000 × g, 4 °C for 30 min. The supernatant was decanted and the 
pellets containing protein extracts stored at -80 °C for further use. 
3.3.4.2 Pressure Disrupted, Pre-Purified Nematocysts 
Venom was provided by Dr. Angel A. Yanagihara. Specifically undischarged nematocysts were 
purified and then disrupted en masse using a French Press 20 K pressure cell (SLM-AMINCO Cat# 
FA078) subjected to a quick 90 s 10,000 × g spin and snap frozen in liquid nitrogen as previously 
described [3]. The venom was stored at -80 °C for proteomic analyses. 
3.3.5 Proteomics Methods 
Sample preparation for the AB SCIEX 5600 mass spectrometer was performed according to the 
protocol described previously [236]. Briefly, the venom pellets generated by CDN and PDN were 
dissolved in 8 M urea, 50 mM ammonium bicarbonate buffer. Sample protein concentrations were 
determined using the 2D Quant Kit (GE Healthcare, Piscataway, NJ, USA). The equivalent of 200 
μg of the CDN and PDN venoms were reduced with 5 mM dithiothreitol at 30 °C for 45 min and 
alkylated with 25 mM idoacetamide for 30 min at RT in the dark. Samples were diluted 1:4 with 50 
mM ammonium bicarbonate buffer followed by tryptic digestion (Sigma–Aldrich, St. Louis, MO, 
USA) at 100:1 protein: trypsin ratio at 37 °C overnight, before they were freeze-dried. Samples 
were then diluted with 5% acetonitrile (ACN)/0.1% formic acid (FA) and subsequently desalted 
with a C18 Toptip (Glygen, Columbia, MD, USA) using: (i) 100% ACN to wet the resin (3 × 150 
ml); (ii) 5% ACN/0.1% trifluoroacetic acid (3 × 150 ml) for tip equilibration and washing steps; and 
(iii) 80% ACN/0.1% TFA (2 × 150 ml) for elution. The eluted protein fragments were freeze-dried 
and then resuspended in 0.5% acetic acid/2% ACN for further analyses. The proteins fragments 
were separated by SCX chromatography on an Agilent 1100 chromatography system. 50 μl of each 
sample were injected onto a Zorbax 300-SCX column (5 μm, 4.6 × 50 mm) (Agilent) at a flow rate 
of 500 μl/min and gradient of 0–5 min, 0% buffer B; 5–25 min, 0%–50% buffer B; 25–27 min, 
50%–80% buffer B; 27–32 min, 80% buffer B; 32–34 min, 80%–0% buffer B. buffer B was held at 
80% for 5 min for washing the column and returned to 1% buffer B for equilibration prior to the 
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next sample injection. Buffer A consisted of 0.5% acetic acid/2% ACN and buffer B contained 
0.5% acetic acid/2% ACN/250 mM ammonium acetate. A total of 72 fractions (250 μl) were 
collected and pooled to give 10 fractions. Pooled fractions were de-salted with C18 Toptip (Glygen) 
and were analysed by LC-MS/MS on a Shimadzu Prominence Nano HPLC (Shimadzu, Kyoto, 
Japan) coupled to a Triple TOF 5600 mass spectrometer (ABSciex, Concord, ON, Canada) 
equipped with a Nanospray III interface. The samples were first de-salted on an Agilent C18 trap 
(0.3 × 5 mm, 5 mm) for 8 min at 30 μl/min. The trap column was then placed in-line with Vydac 
Everest C18 (300 A, 5 μm, 150 mm × 150 um) column for mass spectrometry analysis. Linear 
gradients of 10%–60% solvent B over 45 min at 1 μl/min flow rate was used for peptide elution 
where buffer A consisted of 1% ACN/0.1% FA and buffer B contained 80% ACN/0.1% FA. Full 
scan TOF-MS data was acquired over the mass range 350–1600 and for product ion ms/ms 40–
1600. The mass spectrometer acquired 500 ms full scan TOF-MS data followed by 20 by 50 ms full 
scan product ion high sensitivity mode. A collision energy spread (CE = 40 ± 15 V) was used for 
fragmentation. The acquired MS data were processed using Analyst TF 1.6.1 software (ABSciex). 
Proteins were identified by database searching using ProteinPilot v 4.5 (ABSciex) with the Paragon 
Algorithm using FASTA formatted protein sequences for the C. fleckeri translated proteins obtained 
from the assembled tentacle transcriptome and all publicly available C. fleckeri venom sequences 
using the UniProt database. Search parameters were defined as a thorough search using trypsin 
digestion enzyme iodoacetamide cysteine alkylation emphasis on biological modifications and 
“thorough” search setting. Peptides were considered identified if they could be established at greater 
than 99.0% probability, and proteins were considered identified if they could be established at 
greater than 99.0% probability and contained at least 2 identified peptides and all matched spectra 
were confirmed by manual inspection. The accepted false discovery rates (FDR) for peptides and 
proteins were less than or equal to 1% [237]. In order compare the protein level and quantitative 
results across venom obtained by CDN and PDN, the protein summary of both techniques were 
submitted to Protein Alignment Template (V2.000p, ABSciex, Canada), where the reference protein 
ID and aligned protein ID were designated to PDN and CDN, respectively. This yielded a high 
percent of set proteins being matched with the reference proteins, allowing a fair comparison of the 
high quality ID from each set. 
3.4 Conclusions 
Here we have provided the first detailed description of the C. fleckeri nematocyst transcriptome and 
used this data to facilitate accurate identification of venom components detected by proteomic 
techniques. This combination of approaches permitted robust comparisons of the composition of the 
venom proteome from both pressure disrupted and chemically discharged nematocysts. Whilst both 
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approaches yielded a variety of proteins, our novel approach using ethanol as a chemical stimulus to 
trigger discharge of jellyfish nematocysts led to the identification of more venom toxins than the 
pressure disruption technique. Further studies could determine the relative toxicity in terms of 
hemolytic units (HU50) recovered per microgram of protein obtain by ethanol discharge in 
comparison to those recovered by pressure disruption. In summary, we have demonstrated that the 
use of ethanol as a chemical stimulant for discharge and an extraction solvent for obtaining venom 
proteins from jellyfish tentacles has great potential for future cnidarian venom research. This 
method facilitates accurate venom protein identification and provides a simple, cost-effective 
approach that circumvents the time and technical limitations associated with mechanical disruption. 
Supplementary Materials 
Supplementary materials are available online.  
(http://www.mdpi.com/2072-6651/7/3/936#supplementary) 
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Chapter 4  
Investigating Toxin Diversity in the Tentacle and Oral Arms of the 
Blue Blubber Jellyfish Catostylus mosaicus by Using a Combined 
Transcriptomic and Proteomic Analyses 
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Abstract 
The jellyfish Catostylus mosaicus, known as the Jelly Blubber or Blue Blubber Jellyfish, blooms 
periodically along the Eastern coast of Australia. Contact with human skin can produce immediate 
pain, redness and minor skin irritation. It is postulated that both oral arm and tentacle tissues contain 
stinging nematocysts which are associated with its toxicity. However, no efforts have been made to 
establish the repertoire of venom proteins and peptides expressed in this remarkable animal. By 
using a combination of bottom-up proteomics and transcriptome sequencing, the protein profiles of 
the oral arms and tentacles were studied. The proteomic characterisation demonstrated the toxin 
diversity and expression differences between these two tissues. In transcriptome analyses, more 
than 13,000,000 tentacle and 7,000,000 oral arm Illumina reads were de novo assembled into 
18,000 and 12,000 contiguous. Using homology searches from publicly available sequence 
databases, 9,660 tentacle and 4,790 oral arm proteins were predicted with 122 and 94 potential toxin 
proteins. In the proteomic analyses, over 1200 tentacle and 500 oral arm proteins were identified, 
including a subset of putative toxins. Potential toxin families were identified using MS/MS included 
PLA2, lipases, CRiSPs, cystatins and serine protease inhibitors (Kunitz and Kazal peptides). 
Ethanol-extracted venom confirmed the presence of PLA2 and metalloprotease activity. This study 
revealed venom components of the oral arms and tentacles of a blubber jellyfish for the first time, 
and furthers our understanding of the mechanism of its sting.  
Keywords  
Blue blubber jellyfish, Catostylus mosaicus, venom, oral arm, tentacle, nematocyst, transcriptomics, 
proteomics, MS/MS 
  
The blubber jellyfish Catostylus mosaicus, collected from Manly, Queensland Australia August 
2013. (Photo is provided by Mahdokht Jouiaei from the University of Queensland). 
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4.1 Introduction 
Catostylus mosaicus, a cnidarian of the class Schyphozoa, is a large gelatinous zooplankter jellyfish 
with a bell diameter ranging between 50 mm–350 mm [238]. It is one of the most commonly 
encountered  zooplankter  in estuaries along the Eastern coast of Australia [239]. Human encounters 
with this jellyfish are inevitable, especially during the massive periodical population blooms in 
which the abundance of the jellyfish can increase up to 10-fold within weeks [238]. A sting by this 
widespread species is not life-threatening, although they do cause pain and minor local tissue 
redness and inflammation [35] (unpublished observations). Haemolytic, oedema and hemorrhagic 
induced activities have also been recorded from the crude extract of the homogenized oral arms 
[240]. The C. mosaicus venom delivery system, nematocyst, is located in the bell margins 
(tentacles) and oral arms of medusa, in different sizes and/or relative abundances [30]. This 
suggests that they use diverse organs, and probably diverse toxic substances for prey capture and 
defence.  Surprisingly, in contrast to the extensive work devoted to blubber jellyfish ecology and 
seasonal bloom, the venom composition as well as diversity of each type of toxin in the oral arm 
and tentacle remain almost completely unstudied. 
As the ultimate step in venom characterisation, proteomics technology is a promising tool to 
identify venom proteins and peptides. Most venomics studies to date have been using whole venom 
(shotgun) proteomics, 2-D fractionation (ion-exchange followed by HPLC) and SDS-PAGE 
electrophoresis in order to discover the maximal number of proteins in a sample [14, 91, 99, 241]. 
In addition, advances in high-throughput sequencing and bioinformatics [145] greatly enhance our 
abilities to accurately sequence and analyse venom components detected by proteomic techniques. 
In this study, the combination of transcriptomic and proteomic approaches was applied to 
systematically identify and compare the venom proteins and peptides in the oral arm and tentacle 
tissues. In order to extract venom, a previously described venom extraction technique, ethanol-
induced discharge of cnidae, was utilised [14] to rapidly and efficiently characterise venom 
components and to avoid the time and laborious process associated with mechanical disruption of 
the nematocysts. This study not only provides the first overview of the C. mosaicus tentacle and 
oral arm transcriptome, but also provides extensive information on the repertoire of putative toxins 
in C. mosaicus venom. 
4.2 Results and Discussion  
Increased frequency of C. mosaicus blooms, with increased risk of human exposure to 
envenomation, emphasises the need for accurate characterisation of its venom components for 
treatment of human stings. However, jellyfish venom research has been neglected. In part, this is 
due to the difficulty of venom extraction which is a laborious and time-consuming process [14]. In 
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addition, the venom remains heavily contaminated with mucus even after extraction, which makes 
proteomic study difficult. To facilitate blubber jellyfish venom extraction and identification, a 
previously described chemical extraction technique consisting primarily of dipping tissue into 
ethanol was applied [14]. In order to monitor the discharge of the nematocysts, samples of the oral 
arm and tentacle tissues were taken before (Figure 4-1) and after (Figure 4-2) ethanol treatment. 
These samples were then studied using scanning electron microscopy (SEM) and light microscopy 
(LM).  SEM examination of the undischarged oral arm revealed an uneven surface packed with 
nematocyst batteries (Figure 4-1A). The nematocysts appeared to exist in the ridges (formed by 
nematocyst batteries) when viewed by LM (Figure 4-1B). This study confirmed the presence of four 
distinct types of nematocysts in both oral arms and tentacle as described previously [30]. These 
include pear shaped and oval shaped holotrichous isorhizas (isodiametric tubule with spined 
thorough) (Figure 4-1C–D), and two sized rhopaloids (containing cylindrical shaft) (Figure 4-1E–
F).  
After dipping the oral arms and tentacles into ethanol, the surfaces of both tissues were packed with 
discharged tubules, shafts and nematocysts, although some nematocysts remained undischarged 
(Figure 4-2). It should be mentioned that the primary purpose of this research was to identify the 
venom components of the blubber jellyfish oral arm and tentacle rather than quantify the venom 
obtained by these tissues. It is reasonable to propose that the effect of ethanol on nematocyst 
discharge in C. mosaicus is in line with what was previously reported in box jellyfish Chironex 
fleckeri, suggesting that ethanol can be an affordabale chemical to provide rapid identification of 
jellyfish venom components [14].   
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Figure 4-1. Undischarged nematocysts of C. mosaicus. (A) Low magnification scanning electron microscopy 
(SEM) of an oral arm surface with packed nematocyst batteries; (B) Light microscopy (LM) of a cross-
sectioned oral arm nematocyst battery showing holotrichous isorhizas (black arrows) and rhopaloids (white 
arrows); (C) Pear-shaped holotrichous isorhizae; (D) Oval-shaped holotrichous isorhizae; (E) Large-size 
rhopaloid. Note the operculum (white arrowhead); (F) LM of rhopaloids. Note the coiled tubule around the 
shaft. Scale bars, A 100 µm; B, 50 µm; F 10 µm; C, D, E 1 µm. 
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Figure 4-2. Ethanol-discharged nematocysts of C. mosaicus. (A) Tubules of various oral arm nematocyst 
types after ethanol treatment; (B) shaft of a discharged rhopaloid; (C) An extruded tubule. Note the spines at 
the surface of tubule (arrow); (D) Low magnification light microscopy (LM) of a cross sectioned tentacle 
showing holotrichous isorhizas (black arrows) and rhopaloids (white arrows); (E) Part of the tentacle epidermis 
showing the extruded tubules (black arrow). Scale bars, A 10 µm; B, C 1 µm; D 50 µm; E 10 µm.   
4.2.1 The Transcriptome of C. mosaicus Oral arm and Tentacles  
To accurately identify the venom proteins detected by proteomics, oral arm and tentacle 
transcriptomes for C. mosaicus were generated.  Next generation sequencing of the transcriptomes 
using Illumina platform resulted in 13,392,759 and 7,604,059 assembled bases for tentacle and oral 
arm tissues respectively. Automated de novo assembly resulted in 18,244 and 12,931 transcripts 
with an average length of 734 and 588 bases per contig. Approximately 52% and 37% of the 
tentacle and oral arm contigs provided a high scoring (e-value ≤ 10e-5) match to the SwissProt 
database. To identify potential toxins, assembled transcript were compared to SwissProt toxin 
database using BlASTX. 122 tentacle and 94 oral arm transcripts showed a high scoring (e-value ≤ 
10e-5) sequence homology to known toxins which were further filtered: i) those possessing a low 
scoring (e-value ≥ 10e-5) sequence homology to a toxin protein from the UniProtKB database 
search were removed; ii) sequences without a signal peptide as predicted by SignalP were removed. 
After filtering, 31 and 24 transcripts remained as putative tentacle and oral arm toxins respectively, 
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representing 6 venom families (Figure 4-3A). PLA2 had the highest yield of the venom families, 
with 18 different isoforms identified. Representatives of other toxin families included lipases, 
CRiSPs, cystatins, various serine protease inhibitors (Kazal and Kunitz peptides) and 
metalloproteases (Figure 4-3B).  
 
Figure 4-3. (A) Summary of assembly and annotation of nucleotide sequence data from C. mosaicus tentacle 
and oral arm tissues. (B) Functional grouping of putative toxin proteins/peptides identified in C. mosaicus 
oral arm and tentacle transcriptomes.  
4.2.2 Identified Proteins in C. mosaicus Oral Arm and Tentacle Using Tandem Mass 
Spectroscopy (MS/MS) 
Using a combined proteomic approach (shotgun proteomics, 1D SDS-PAGE, 2-D fractionation), 
898 and 1143 proteins in the oral arm and tentacle respectively were identified. The majority were 
detected using shotgun analysis and 2-D fractionation (Figure 4-4A).  The proteins detected 
included oxido-reductase (oxidases and peroxiredoxins), ATP synthases and ATPases, heat shock 
proteins, chaperones, ribosomal proteins, hydrolyses and proteases (collagenase metalloproteinase), 
voltage dependant channel proteins, and putative toxins identified in transcriptome analysis. Among 
the identified proteins, structural proteins were in high abundance. This includes nematocyst out 
wall antigen (NOWA) which is a component of the nematocyst capsule in cnidarians [242]. These 
findings of nematocyst capsule homologues in our samples may suggest the presence of capsule 
matrix contamination since using ethanol to induce nematocyst discharge may disintegrate the 
capsule wall. In addition, homologues of vascular endothelial growth factor (VEGF) and receptors 
in the oral arm and tentacle were detected. The homologous protein has previously been 
characterised in hydrozoan Podocoryna carnea and is known to be involved in tube formation 
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[243]. Representatives of other structural proteins included actin, myosin, collagen, tubilin, clathrin, 
deoxyribonuclease with homology to plancitoxin from Crown-of-thorns starfish (Acanthaster 
planci) [244] and an alpha-macroglobulin containing protein family with homologies to 
Nematostella, human complement protein C3 and cobra venom factor [245, 246]. These transcripts 
do not contain a signal sequence and provide high-scoring matches to non-venom proteins in 
GenBank, which suggests a biological/structural role distinct from envenomation.  
GO-term annotation of the identified proteins revealed a variety of putative functions and biological 
processes (Figure 4-4). Level 2 molecular functions were dominated by proteins associated with 
‘catalytic activity’ and ‘binding’ (Figure 4-4B). Level 2 biological process GO-terms highly 
represented among the identified proteins included cellular and metabolic processes (Figure 4-4C).   
 
Figure 4-4. Identified Proteins in C. mosaicus Oral arm and Tentacle Using MS/MS. (A) Total number 
of proteins identified in in-gel digestion (G), Shotgun (S) and SCX Chromatography (C); (B) Level 2 
‘Molecular Function’ GO-term analysis; (C) Level 2 ‘Biological Process’ GO-term analysis.  
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4.2.3 Toxin Proteins Identified in C. mosaicus Oral Arm and Tentacle Using Tandem Mass 
Spectroscopy (MS/MS) 
Whilst many protein types identified in this organism were clearly associated with conserved 
functions related to structure, transport and metabolism, a number of other proteins likely 
represented putative venom toxins. Phospholipases and lipases were the most abundant classes of 
toxins, followed by proteins containing ShK domain (CRiSPs), cystatins and serine protease 
inhibitors. It should be mentioned that it is difficult to estimate the diversity of oral arm and tentacle 
venom components from SDS-PAGE electrophoresis due to the extent of mucus contamination, 
preventing protein migration through the gel. In addition, individual proteins can have variable 
mobility, depending on the degree of post-translational modification (Figure 4-5).  
 
Figure 4-5. C. mosaicus venom proteins. Total protein from oral arm (lane 1) and tentacle (lane 2) in a 12% 
SDS-PAGE gel. Lanes were divided into 15 gel slices (dotted lines) and subjected to in-gel digestion and 
protein identification. The numbers in each gel refer to the proteins displayed in Table 4-1.  
4.2.3.1 Secretory Phospholipase A2 (sPLA2) 
Several proteins with conserved sPLA2 domain (IPR016090) were identified in the oral arm and 
tentacle venoms (Table 4-1). PLA2 proteins consist of a large family of enzymes with 15 distinct 
scaffolds and many subgroups [247]. PLA2 scaffolds have been widely distributed within the  
animal kingdom where they play important roles in vital physiological and pathological functions 
such as signal transduction, dietary and endogenous phospholipid catabolism, and inflammation 
[94]. Group III PLA2 toxins are particularly remarkable in that they have been independently 
recruited in several venomous animal lineages. Derived toxic functions include neurotoxic activity 
in honeybee (Apis mellifera) venom in which they specifically bind to N-type receptors in brain 
membrane [248], anti-platelet activity in Heloderma venoms [249], haemolysin in Eastern Indian 
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scorpion (Mesobuthus tumulus) venom [250], inhibition of both skeletal and cardiac ryanodine 
receptors (calcium release channels) in Emperor scorpion (Pandinus imperator) [251], allergic 
reaction to bumblebee (Bombus terrestris) venom [252] and apoptotic cell death in bumblebee 
(Bombus ignitus) venom [253].  The first cnidarian GIII PLA2 was isolated and partially sequenced 
from jellyfish Rhopilema nomadic (Schyphozoa) and a toxic function to fishes was proposed [40]. 
In addition, EST homologous to bee venom GIII PLA2 was identified in Nematostella vectensis  
[98] and Hydra magnipapillata [254].  In C. mosaicus the hemolytic activity of the oral arm is 
proposed to be associated with PLA2 present in the extract [255]. However, extensive studies need 
to be conducted in order to determine whether protease activity is associated with haemorrhagic 
activity. Strikingly, the putative venom PLA2 identified in the oral arm and tentacle show high 
levels of sequence identity (47–48%) to Gila monster (Heloderma suspectum) venoms which 
belong to GIII PLA2. In addition, the putative venom protein shows 38%–45% sequence identity to 
other toxic GIII PLA2s from the venoms of honeybee (Apis spp.), bumblebee (Bumbus spp.), and 
scorpion venoms. A PLA2 homologue in the oral arm and tentacle venoms contains a signal peptide 
of 16 amino acids. The mature protein has a theoretical molecular size of 15.31 kDa and isoelectric 
point of 6.42. The mature peptide consists of 136 amino acids including 8 cysteine residues. More 
importantly, core residues involved in catalytic activity (PLA2 histidine active site: C-C-(any but 
Proline) -x-H193-(any but LGY)-x-C) and Ca
2+
 binding site (W167, G169, G171, D194) are 
conserved (Figure 4-6).  
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Figure 4-6. Sequence alignment of GIII PLA2 precursors from 1. Bombus terrestris (P82971), 2. Apis 
mellifera (P00630), 3. Catostylus mosaicus (Contig 2336-6795), 4. Hydra vulgaris (T2M479), 5. Heloderma 
suspectum (P16354), 6. Nematostella vectensis (A7RM30), 7. Mesobuthus tamulus (Q6T178). 
Two isoforms of GIX PLA2 proteins were identified in the C. mosaicus oral arm.  GIX PLA2 is 
basic proteins with a theoretical isoelectric point of ~9 and molecular weight of ~18. Both putative 
venom proteins contain N-terminal signal peptide for secretion, 10 conserved cysteine residues for 
putative disulphide formation, and conserved histidine in the site of catalytic activity (Figure 4-7). 
The first GIX PLA2 venom protein was described in the venom of the marine snail Conus magus 
(UniProt:  Q9TWL9). Interestingly this toxin did not show PLA2 enzymatic activity and its toxicity 
was instead the blocking of L-type Ca channels in rat brain [256]. Cnidarian EST homologues to 
Conus GIX PLA2 have been identified in the jellyfish Rhopilema esulentum (Schyphozoa) 
(UniProt: X2G7F0) and N. vectensis [98]. Noticeably, the putative PLA2 venom proteins in C. 
mosaicus showed high level of sequence identity to cnidarian GIX PLA2 homologues. A high 
degree sequence identity with venom GIII and GIX PLA2s suggests that putative PLA2s may 
contribute to toxic activity of C. mosaicus (such as hemolytic or neurotoxic activity), and should 
therefore be further investigated to characterise their structure-function relationships and role in 
blubber jellyfish envenoming. 
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Figure 4-7. Sequence alignment of GIX PLA2 precursors from 1. C. mosaicus (Contig 5027), 2. C. 
mosaicus (Contig 2769), 3. Rhopilema esculentum (X2G7F0), 4. Nematostella vectensis (A7RMJ0), 5. 
Conus magus (Q9TWL9). 
4.2.3.2 Lipases 
Two isoforms of lysosomal acid lipase / cholesteryl ester hydrolase were detected in the tentacle 
venom (Table 4-1). These putative venom proteins have the same domain structure as found in 
characterised snake venom lipases and non-venom cnidarians ESTs (Figure 4-8). They are large 
proteins with a molecular weight of ~44 kDa and a signal peptide. Although in venom, the 
biological function is unknown; their presence in the proteome suggests that they may include roles 
in the digestion of prey.  
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Figure 4-8. Sequence alignment of lipid-precursors from 1. C. mosaicus (Contig 1781), 2. C. mosaicus 
(Contig 5698), 3. Crotalus adamanteus (J3SDX8), 4. Hydra vulgaris (T2MGH6), 5. Nematostella vectensis 
(A7SL62). 
4.2.3.3 Putative CRiSP C. mosaicus Venom Proteins 
Three proteins detected in the C. mosaicus tentacle and one protein in oral arm tissue belongs to 
Cysteine Rich Secreted Proteins (CRiSP) superfamily (Table 4-1). CRiSP related proteins have 
been convergently recruited in the venoms of reptiles, ticks, cone snails, scorpions, spiders, 
cephalopods, insects (proboscis and stinger) and vampire bats [90, 91]. They are multidomain 
proteins containing N-terminal CAP (CRiSP, antigen 5 [Ag5], pathogenesis-related 1 [Pr-1] domain 
(s)) and a C-terminal cysteine-rich domain (except for cephalopods) that inhibit a number of ion 
channels [90]. It has been suggested that the co-operation between CAP and cysteine-rich domains 
facilitates the interaction with the ion channels [257].  CAP proteins in the cleractinian corals 
(Cnidaria, Anthozoa) and snakes are proposed to be involved in neurotoxicity [80, 257-260].  The 
blubber jellyfish CRiSP proteins showed high level of sequence similarity to CRiSP from Malo 
kingi, N. vectensis and snake venom [258, 259] (Figure 4-9). The cysteine-rich C-terminal domain 
(IPR003582 ShKT) contains six cysteine residues with a distinctive XCXD pattern terminates, with 
the characteristic pattern CXXTCXXC that is homologues to sea anemone voltage-gated potassium 
(Kv) channel toxins [261, 262].   
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Figure 4-9. Sequence alignment of CRiSP precursors from 1. C. mosaicus (Contig 5022-tentacle), 2. C. 
mosaicus (Contig 7484-tentacle), 3. C. mosaicus (Contig 3410-tentacle), 4. Catostylus mosaicus (Contig 
2043-oral arm), 5. Nematostella vectensis (A7T1T5), 6, Malo kingi (B1A0E5), 7. Heteractis magnifica 
(O16846), 8. Anemonia erythraea (Q0EAE5), 9. Protobothrops jerdonii (Q7ZZN9), 10. Trimeresurus 
stejnegeri (P60623). Disulfide bridges in the CRD are indicated by lines. 
Considering that the identified C. mosaicus CRiSP proteins have putative signal peptides and 
cysteine-rich C-terminal domain with a homologous ShK toxin, it can be suggested that jellyfish 
CRiSP proteins may represent a part of the animal allomonal system. It also suggests that the CRD 
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domain may have been independently recruited into multiple domain proteins with differing 
functions to facilitate the specificity and affinity of venom proteins for their targets.  
4.2.3.4 Putative Venom Cystatin 
A member of family 2 cystatins was detected in the crude venom extract from C. mosaicus tentacle 
and oral arm (Table 4-1). Cystatins are papain-like cysteine protease (CP) inhibitors that are 
isolated from various tissues and fluids from diverse organisms. They play an important regulatory 
role in inhibition of endogenous and pathogen CPs for protection of cells against tissue injury and 
invaders [263].  They have been found  in a wide range of venomous animals including jellyfish 
[264], stingray [265], snake [266], tarantula [267] and  haematophagus ticks [268].  Mutagenesis 
and X-ray crystallography studies indicate there is an N-terminal loop consisting of a glutamine 
valine- glycine (Q-X-V-X-G) residue and a C-terminus prolin/serin-typtophan (P/S-W) in the form 
of a wedge-shaped structure that is essential for inhibition of the active site of C1 family cysteine 
proteases [264, 269, 270]. There is no evidence that cystatins are involved in venom toxicity, 
however they may protect the venom proteins/peptides from inactivation by defensive enzymes of 
the envenomated victim [271]. Here, the cystatin identified in blubber jellyfish venom contains a 
putative 18-residue signal peptide and a mature protein of 129 amino acids with two intra-molecular 
disulfide bonds, which shows a high level of sequence identity (30-42%) to family 2 cystatins 
(Figure 4-10A). It has a molecular weight of 14.54 kDa and isoelectric point of 8.67. Despite the 
similarities, our phylogenetic analysis of the cystatin gene families revealed that blubber jellyfish 
cystatin is non-homologous to the cystatins previously recovered from other venomous animals 
(Figure 4-10B). This data suggests that cystatins have been recruited into venoms  on multiple 
occasions, a finding which is in accordance with the previous study [265]. The fact that the same 
gene families are recruited several times independently suggests that the non-toxic activity of these 
proteins have become toxic via gene-duplication, accompanied by adaptive evolution [90].   
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Figure 4-10. (A) Sequence alignment of cystatin-precursors from 1. C. mosaicus (contig 2707-7304), 2. 
Cyanea capillata (Q331K1), 3. Chilobrachys guangxiensis (B1P1J3), 4. Pogona barbata (Q2XXN5), 5. 
Oxyuranus microlepidotus (E3P6N5), 6. Crotalus adamanteus (J3RYX9), 7. Homo sapiens (Q15828), 8. 
Gallus gallus (P01038), 9. Oncorhynchus keta (Q98967). (B) Precursor phylogenetic reconstruction. 
Branches highlighted in red indicate cystatins that have been recovered or cloned from the venom glands of 
venomous animals (snake, cnidarian, stingray, tick).  
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4.2.3.5 Serine Protease Inhibitors 
Several peptide types with plesiotypic serine protease-inhibiting activity (Kunitz and Kazal 
peptides) were identified in the venom extract of both tissues (Table 4-1). Kunitz are serine protease 
inhibitors that have been convergently recruited into the venom and oral secretions of a wide range 
of animals, exhibiting anticoagulation activity in vampire bat secretions [91], brown snake 
(Pseudonaja textilis textilis) venom [272] and cattle tick [273]; antifibrinolytic activity in 
bumblebee (B. terrestris) venom [274],  and calcium / potassium channel blocking activity in the 
venoms of eastern green mamba [275] and scorpion [276]. Notably, they have also been identified 
previously in cnidarian taxa. In the venom arsenal of sea anemones they exhibit a plesiotypic 
activity of trypsin-inhibition, but possess additional apotypic activities including potassium channel 
blockage [31, 76, 78, 277, 278]. BLAST searches of the Kunitz peptide detected in this study 
surprisingly retrieved Kunitz homologues in snakes, scorpions, bumblebee and sea anemones, 
where their toxic activity have been well characterised (Figure 4-11). The mature peptide has 
common features with other known secreted venom Kunitz such as N-terminal signal for secretion, 
6 cysteine for disulphide formation and conserved residues in the site of catalytic activity. It has a 
theoretical molecular weight of 7.36 kDa and isoelectric point of 7.73.  This peptide is one of the 
most abundant of those detected in 1D SDS-PAGE (Band 1, Figure 4-5, Table 4-1). Considering 
these observations, this form of toxin may represent the first Kunitz peptide that has been identified 
in the venom of a Schyphozoa jellyfish, C. mosaicus.  
 
Figure 4-11. Sequence alignment of kunitz precursors from 1. C. mosaicus (Contig 12914), 2. Heteractis 
crispa (P0DMJ5), 3. Anemonia sulcata (Q9TWF8). 4. Actinia equina (P0DMW6), 5. Bombus terrestris 
(D8KY58), 6. Hadrurus gertschi (P0C8W3), 7. Dendroaspis angusticeps (P81658). 
A mono domain kazal serine protease inhibitor with homology to coral Melithaea caledonica 
(UniProt accession number P82968) was discovered in the oral arm and tentacle venoms (Figure 4-
12). The mature peptide has a theoretical molecular weight of 15 kDa which is detected in SCX as 
66 
well as 1D SDS-PAGE (Band 4, Figure 4-5, and Table 4-1). It has been proposed that coral protease 
inhibitor inhibits trypsin, kallikrein, subtilisin Carlsberg, human leukocyte elastase, porcine 
pancreatic elastase and chymotrypsin. In addition to venoms for which enzyme activity has been 
reported, a five-domain protease inhibitor has also been identified in the venom of  box jellyfish (C. 
fleckeri) venom [14], but the corresponding enzyme activity has not yet been obtained. It can be 
hypothesised that as a member of the venom proteome which is presumably injected during a sting, 
serine protease inhibitors could contribute to the symptoms of envenomating by inhibiting the rapid 
degradation of the venom protease by endogenous enzymes of the animals themselves or of the prey 
[279].  
 
Figure 4-12. Sequence alignment of kazal precursors from 1.Catostylus mosaicus (Contig 4371-3114), 2. 
Melithaea caledonica (P82968), 3. Chironex fleckeri (Contig 134).  
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Table 4-1 Summary of venom proteins identified in the oral arm and tentacle of C. mosaicus.  
 
NOTE. The type of evidence used for identification: Transcriptome (T), Shotgun (S), SCX Chromatography 
(C), and in-gel digestion (G). 
 
Transcriptome 
ID 
 
Best 
Venom hit 
Accession 
# 
Oral 
arm 
Tentacle Conserved domain Known function 
PLA2 
2336 
P80003 
T, S, 
C, G 
(4) 
      _ 
Phospholipase A2 domain 
(IPR016090);  
Phospholipase A2, active site 
(IPR013090) 
Neurotoxic [40, 
248], inhibition of 
Ca release [251], 
anti platelet [249], 
hemolytic [250], 
allergen [252], 
apoptotic cell death 
[253] 
6795 _ 
      T, S, 
C 
2769 
Q9TWL9 
T, S, 
G (1) 
        _ 
Phospholipase A2 domain    
(IPR016090); 
 Phospholipase A2, active site 
(IPR013090) 
Catalyses the 
hydrolysis of the 
sn-2 ester in a 
calcium dependent 
manner [256] 
5027 T, C 
Lipases 
1781-5698 J3SDX8 _ T, S 
Lipase eukaryotic IPR025483); 
Alpha/Beta hydrolase fold 
(IPR029058); Partial AB-
hydrolase lipase domain 
(IPR006693) 
Unknown 
CRiSPs 
5022-7484-
3410 
Q7ZZN9 
_ 
T, S, C, 
G (22) 
Cysteine-rich secretory protein, 
allergen V5/Tpx-1-related 
(IPR001283); CAP domain 
(IPR014044); ShKT domain 
(IR003582); Allergen V5/Tpx-1-  
related, conserved site 
(IPR018244) 
Neurotoxic  
[80, 257-260] 
2043 
T, S, 
C, G 
(7,8) 
_ 
Cystatins 
2703 
Q331K1 
T, S, 
G (3) 
_ Proteinase inhibitor I25, cystatin 
(IPR000010) 
Potential protease 
inhibitor [271] 
7304 _ T, C 
Serine Protease inhibitors 
Kunitz-12914 P0DMJ5 
T, G 
(1) 
_ 
     Pancreatic trypsin inhibitor 
Kunitz domain(IPR002223); 
Proteinase   inhibitor I2, Kunitz, 
conserved site (IPR020901) 
Protease inhibitor, 
neurotoxin  
[31, 76, 78, 277, 
278] 
Kazal-3114 
P82968 
T, C, 
G (4) 
 
Kazal domain 
(IPR002350) 
Unknown 
Kazal-4371 _ T, C 
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4.2.4 Enzymatic Activity 
Next the enzymatic activity was assessed to determine if treatment with ethanol during the chemical 
extraction process has an effect on PLA2 and metalloproteases activity (n = 3). The in vitro PLA2 
assays with ethanol-extracted C. mosaicus oral arm and tentacle venoms produced a slight increased 
in absorbance (Figure 4-13A). Consistent with transcriptomic and proteomic findings, both oral arm 
and tentacle venoms exhibited PLA2 activity, while the oral arm showed higher activity than the 
tentacle (Figure 4-13B).  
Subsequently the metalloprotease activities of the oral arm and tentacle crude venom were assessed 
on gelatine and casein substrates. Consistent with the transcriptomics, intense enzymatic activity 
was observed in tentacle crude venom between 20–25 kDa when gelatine was used as a substrate 
(Figure 4-13C). No activity was observed in oral arm crude venom. Although in this study no 
metalloproteases were detected in the C. mosaicus proteome, one astatine-domain containing 
metalloproteases was identified in the tentacle transcriptome. It contains a signal peptide with 35 
amino acid residues and a theoretical molecular weight of 23 kDa which shows a high level of 
sequence identity (32–43 %) to the genus Loxosceles venoms and N. vectensis venom (NEP-6). 
Astasin-like proteins with toxic activity are recruited in the venom from spiders of the genus 
Loxosceles  [280] where they may be involved in degrading the extracellular matrix, thereby 
providing other venom toxins with better access to their targets. Alternatively they might play a role 
in proteolytic processing of other venom toxins or digestion of prey [228]. In cnidarians, astacin 
domain proteins are found in the nematocyst and pharyngeal gland of the sea anemone N. vectensis 
[48], nematocysts of the Box jellyfish C. fleckeri [14] and hydrozoans Hydractinia echinata [281], 
H. magnipapillata [282] and Podocoryne carnea [283]. Although their role in envenomation 
remains to be determined, they possibly share a role in regulation of developmental processes and 
have acquired a special role as digestive enzymes or proteolytics for the activation of the toxin 
domain [48, 283].  
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Figure 4-13. Enzymatic activity of C. mosaicus. (A) Absorbance times for C. mosaicus oral arm and 
tentacle (100 µg). (B) The sPLA2 activity (µmol/min/mg) for each venom.  Values presented as a mean of 
three replicates (n = 3), error bars indicate SD. (C) Tentacle (lane 1) and oral arm (lane 2) venom separated 
using a 10% Zymogram PAGE, gelatine substrate. No proteolytic activity was detected in the oral arm 
venom (lane 2) with gelatine substrate. The band with metalloprotease activity is shown in red. The gels 
were stained with Colloidal Coomassie Brilliant Blue G250. 
4.3 Experimental Section 
4.3.1 Specimen Collection 
Nine mature live specimens of C. mosaicus were collected by dip net from Manly Beach, 
Queensland, Australia, during the summer 2013, 2014 and 2015 by Mahdokht Jouiaei, Scott C. 
Cutmore and Bryan G. Fry. For transcriptome analysis, equal proportions of fresh tentacles (CMF) 
and oral arms (CMT) from each specimen were collected manually and pooled to remove the effect 
of individual variability.  The pooled samples were immediately frozen in liquid nitrogen before 
storage at -80 °C until use.   
4.3.2 Nematocyst Morphology 
Sample preparation for histology and cryo-SEM studies as described previously [14].  
4.3.3 RNA Extraction and Transcriptome Library Construction 
Total RNA was isolated from 200 µg of the pooled frozen tentacles and oral arms using the 
standard TRIzol Plus RNA purification kit (Life Technologies, Carlsbad, CA, USA). RNA quality 
was assessed using a Bioanalyser (Agilent, Santa Clara, CA, USA). A total of ~500 ng Messenger 
RNA from each tissue was isolated and purified using standard Dynabeads mRNA DIRECT Kit 
(Life Technologies, Oslo, Norway). A cDNA library was constructed by fragmentation of mRNA 
with divalent cations and heat, synthesis of double-stranded cDNA, DNA fragment end repair 
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(blunt ending of DNA fragments), 3' adenylation of DNA fragments, sequencing adapter ligation 
(utilising T-A pairing of adapter and DNA fragments), followed by amplification of library using 
PCR. cDNA sequencing was carried out on an Illumina MiSeq machine (Australian Genome 
Research Facility), generating 7,604,059 and 13,392,759 reads for oral arms and tentacles 
consecutively.  
Paired-end read data was assembled into 12,931 and 18,244 contigs using CLC Genomics platform 
(Workbench 8.0.1) with the minimum transcript length set to 200bp. Assembled contigs were 
annotated with the AGRF’s Expressed Sequence Tag Database servers using the BLASTX 
algorithm with a significance threshold of 1e-3, to provide BLAST annotations against SwissProt 
protein database. Some sequences annotated ambiguously were confirmed using Expasy (UniProt 
Knowledgebase (Swiss-Prot + TrEMBL), Uniref100) comparison. Contigs were then translated 
using CLC Genomics Workbench 5 (CLC bio, Aarhus, Denmark) to all 6 reading frames to provide 
a sequence database for the proteomic characterisation of the venom components. Additionally, 
sequences identified proteomically were scanned for the presence of signal peptides with SignalP 
4.1 Server (http://www.cbs.dtu.dk/services/SignalP/) [234]. Alternatively the non-classically 
secreted proteins were predicted by Secretome 2.0 Server 
(http://www.cbs.dtu.dk/services/SecretomeP/). Propeptide cleavage site was predicted using  ProP 
1.0 server (http://www.cbs.dtu.dk/services/ProP/ ), and the functional domains and gene ontology 
(GO) were checked with InterPro (http://www.ebi.ac.uk/interpro/) [235] and  Conserved domain 
Architecture Retrieval Tool (http://www.ncbi.nlm.nih.gov/Structure/lexington/lexington.cgi). The 
theoretical molecular weight was also calculated with ExPASy Compute pI/Mw tool 
(http://web.expasy.org/compute_pi/).  
4.3.4 Venom Extraction 
The venom from each specimen was collected by ethanol-induced discharge [14]. The fresh 
tentacles and oral arms were immersed in 1:4 absolute ethanol for 30 s at room temperature. The 
ethanol-containing pooled venom was then kept at -80 °C overnight to precipitate the proteins and 
peptides. The solution was then centrifuged at 14,000 × g, at 4 °C for 30 min. The supernatant was 
removed and the protein pellets containing protein and peptides extracts stored at −80 °C for further 
use.  
4.3.5 Proteomics  
4.3.5.1 One dimensional (1D) SDS-PAGE 
Initially it was found that the venom had a high concentration of salt which interrupted the gel 
electrophoresis. Thus, the venom solutions from tentacle and oral arm were desalted with Visaspin 
Concentrators (GE Healthcare, UK) with a molecular weight cut-off of 3,000 Da. The final material 
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was then quantified by Nanodrop spectrophotometry (Thermo Scientific, Wilmington, DE, USA) 
and freeze-dried. Using protocols previously described [241, 265] 40 µg of lyophilised venom 
proteins from each tissue were reconstituted in purified water and laemllie sample buffer (BIO-
RAD, USA), reduced by heating at 100 °C for 4 min, loaded onto a 12% polyacrylamide gel and 
covered with tris-glycine running buffer. Electrophoresis was performed with a constant voltage of 
90 V for approximately 90 min. The gel was removed and stained in 0.2% colloidal Coomassie 
brilliant blue G250 (BIO-Rad USA) overnight and destained in 1% acetic acid/H2O. 
4.3.5.2 Protein digestion 
Using protocols previously described [265] in-gel tryptic digestion and extraction was undertaken to 
extract peptides for mass spectrometry analysis. The visible 1D bands were picked and destained 
with 50 mM NH4CO3/50% ACN before reducing with 10 mM DTT (30 min, 60 °C) and alkylating 
with 55 mM idoacetamide (30 min at RT and in the dark). The bands were briefly rinsed in 50 mM 
ammonium bicarbonate for 1-2 min twice followed by dehydrated in 100% ACN.  The digestion 
was performed with trypsin (Sigma–Aldrich, St. Louis, MO, USA) at 100:2 protein: trypsin ratio at 
37 °C overnight. Subsequently the digested proteins were extracted from the gels by using 20 µl of 
1% formic acid (FA) for 20 min at RT followed by 20 µl of 5% ACN / 1% FA for 20 min at RT. 
For shotgun sequencing, the venom pellets from each tissue were resuspended in freshly prepared 8 
M urea, 50 mM ammonium bicarbonate buffer at 1:10 (w:v) and vortexed briefly for 2 min at room 
temperature.  The venom solutions were then centrifuge at 15,000 × g for 10 min to remove 
undissolved cell pellet, and protein concentration in supernatant containing the soluble venoms 
were determined using the 2D Quant Kit (GE Healthcare, Piscataway, NJ, USA). Using protocol 
previously described [14], crude venoms (equivalent of 5 µg of protein from oral arm and tentacle) 
were first desalted with a C18 Toptip (Glygen, Columbia, MD, USA) and freeze-dried before they 
were solubilised with 20 µl of Milli Q and 2.5 µl of 1 M ammonium carbonate. A total of 25 µl per 
sample (97.5% ACN, 2% idodethanol and 0.5% triethylphosphene) was added followed by 
incubation at 37 °C in the dark for 2 hours. Samples were concentrated using a speed-vacuum 
centrifuge and resuspended in 12 µl of 40 mM ammonium bicarbonate buffer before tryptic 
digestion (Sigma–Aldrich, St. Louis, MO, USA) at 100:5 protein: trypsin ratio at 37 °C overnight. 
Sample preparation and digestion prior to SCX chromatography was performed on 400 µg of the 
venom from oral arm and tentacle using protocol previously described [14]. Prior to MS analysis, 
digested crude venoms, in-gel digested proteins and pooled fractions from SCX chromatography 
were de-salted using C18 Toptip to avoid overloading the detector. They were then concentrated 
with a speed-vacuum centrifuge to remove residual acetonitrile (ACN) and resuspended in 100 µl of 
5% ACN/1% FA. 
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4.3.5.3 LC− ESI−MS/MS  
Using protocols previously validated [14], venoms were separated on a Shimadzu Prominence 
nanoLC system (Shimadzu, Kyoto, Japan) and analysed on a Triple-TOF 5600 instrument 
(ABSciex, Concord, ON, Canada) equipped with a Nanospray III interface. Samples were first 
desalted on an Agilent C18 trap column (300   pore size, 1.8 µm, 2.1 mm × 100 mm) at 400 μl/min 
flow rate for 15 min. The trap column was then placed in-line with Vydac Everest C18 (300 A, 5 
μm, 150 mm × 150 um) column for mass spectrometry analysis. Linear gradients of 10%–60% 
solvent B (90% ACN, 0.1% FA) in 1% ACN/0.1% FA over 45 min at 1 μl/min flow rate was used 
for peptide elution. IDA injections were analysed in duplicates (technical replicates). The mass 
spectrometer acquired 500 ms at a rate of 20 scans per second with a cycle time of 50 ms full scan 
product ion data in an Information Dependant Acquisition (IDA) mode. Precursor ions were 
selected between 40 and 1800 m/z with an intensity of at least 200 counts per second and a charge 
state of +2 to +5. The data was acquired and processed using PeakView® version 2.1 (ABSciex, 
Forster City, CA).  
4.3.6 Bioinformatics Analysis 
Mass spectrometry (MS) data from IDA analyses were combined and searched using ProteinPilot 
software v4.5 (ABSciex, Forster City, CA) with the Paragon Algorithm using FASTA formatted 
protein sequences for the C. mosaicus translated proteins obtained from the assembled tentacle and 
oral arm transcriptomes. Search parameters were defined as trypsin digestion, iodoethanol as cys-
alkylation (for shotgun) and iodoacetamide (for ID SDS-PAGE and SCX chromatography), FDR 
analysis, and emphasis on biological modifications and “thorough” search setting. The protein 
identifications were accepted if they could be established at greater than 99.0% probability and 
contained at least one identified peptide with more than 99% confidence, and all matched spectra 
were confirmed by manual inspection to eliminate false positive. The 1% false discovery rates 
(FDR), at the peptide and protein levels, were included in the statistical analyses.  
4.3.7 Phylogenetic Analyses 
Toxin transcripts identified in the proteome were blasted against the UniProt database 
(http://www.expasy.org/tools/blast/) to identify putative venom and non-venom gene homologues. 
To minimize confusion, all sequences obtained in this study are referred to by their Contig numbers, 
and homologues sequences from previous studies are referred to by their UniProt/Swiss-Prot 
accession numbers (http://www.expasy.org/cgi-bin/sprot-search-ful). Amino acid sequences were 
aligned using CLC Main Work Bench 6 (CLC-Bio) using default parameters and very accurate 
(slow) alignment. When presented as sequence the signal peptides are shown in lowercase letters 
and cysteines are highlighted in black; > and < indicate incomplete N/5′ or C/3′ ends, respectively. 
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The alignments were inspected visually for errors. Bayesian phylogenetic analysis performed on the 
amino acid data sets allowed the reconstruction of the molecular evolutionary histories of putative 
C. mosaicus toxins. Bayesian inference implemented in MrBayes 3.2.3 [284] was used by running a 
minimum of 15 × 10
6
 generations in 4 chains and every 100th generation was sampled. The analysis 
was performed using lset rates = invgamma with prset aamodelpr = mixed command to optimise 
between the 9 amino acid substitution matrices implemented in MrBayes.  
4.3.8 PLA2 Activity Testing 
Hydrolysis of the thio ester bond at the sn-2 position by PLA2 was performed using secretary PLA2 
(sPLA2) Assay Kit (Cayman Chemical Company, Ann Arbor, MI, USA). Briefly, Diheptanoyl 
Thio-PC was used as a substrate in an Assay Buffer containing 25 mM Tris-HCl, pH 7.5, 10 mM 
CaCl2, 100 mM KCl and 0.3 mM Triton X-100. Free thiols were detected using DTNB (5, 5’dithio-
bis-(2-nitrobenzioc acid)).  Bee venom was used as positive control. 10 µl aliquots (1, 10, 20, 100 
µg) of the desalted samples were added to two wells in 96-wall plates contacting 10µl DTNB (10 
mM in 0.4 M Trsi-HCl, pH 8.0), and 5 µl Assay Buffer. The reaction was initiated by adding 200 µl 
substrate solution (1.66 mM) to all the walls. Absorbance readings were recorded at 405 nm per min 
using a BMG FLOUstar OPTIMA (BMG LABTECH Germany) to obtain 10 time points. The PLA2 
activity, micro-moles of fatty acid released per minute per milligram of protein, was calculated 
using the equation:  
    2          (μmol/min/mg) = Δ  405/min10.66  −1 × 0.225  /0.01    
sPLA2 activity was expressed as mean ± SD and analysed using GraphPad prism 6.0. To obtain 
reproducible results, only the blubber jelly venom PLA2 measurements that are in the detection 
range of the assay (equivalent of an absorbance increase of 0.01 to 0.1 per min) were reported.  
4.3.9 Metalloprotease Activity Testing 
In order to investigate crude venom for proteolytic activity, Zymogram PAGE was performed on 
10% (gelatine) and 12% (casein) substrates. Samples of 40 µg concentrations were prepared for 
each tissue. Methods followed those supplied; Bio-Rad Zymogram PAGE protocol with ready-
made 10% gelatine and 12% casein gels. Gels were stained in coomassie brilliant blue G-250 for 1 
hour and stored in 100 ml Milli Q. Gelatinases, Matrix Metalloprotease (MMP) 2 and MMP 9 can 
be detected via 10% Zymography, while MMP 1, MMP 7, MMP 12, and MMP 13 are detected via 
12% Zymography. By performing both zymography tests with the same venom under the same 
conditions, direct comparison between venoms can be made.  
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4.4 Conclusion and Future Directions 
The principle aim of this study was to identify venom proteins in tentacle and oral arms of C. 
mosaicus that could be responsible for its toxicity. Through the transcriptomic and proteomic 
investigations, the oral arm and tentacle venoms were shown to share a number of the same protein 
toxins. However, the oral arm venom was found to express Kunitz peptide while tentacle expressed 
two isoforms of lipases and one isoform of metalloprotease. These differences may have resulted 
from selective discharge of nematocysts within individuals in response to various mechanical, 
chemical and neural stimuli.  If jellyfish can respond differently to various stimuli, then differences 
in transcripts between oral arm and tentacle could account for the observed variations in venom 
proteomes, as transcripts are a snapshot in time of any toxin that the venom gland is coding. No 
studies have yet investigated this hypothesis. The enzymatic activities of the venom toxins during 
the ethanol extraction process were confirmed using PLA2 and metalloprotease assays in vitro. The 
results demonstrate that addition of ethanol does not completely inhibit activity and the venom 
retains bioactive. Therefore, denaturing is not a significant issue during the extraction process as 
long as enzymes have a high disulphide content which stabilizes their secondary structure or they 
are highly glycosylated, which protects the enzymes from denaturing. Further studies should 
determine the extent of the enzymatic activity when ethanol is added compare to the control (un-
treated) venom.   
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Chapter 5  
Pharmacological Profile of Venom Isolated From Hell’s Fire 
Anemone Actinodendron sp.: A Preliminary Study 
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Abstract 
This study contributes to the areas of proteomics, pharmacological properties and biodiscovery 
potentials of hell’s fire anemone (Actinodendron sp.), for which there are, to our knowledge, very 
few published studies. Using a combination of LC-ESI-MS, MS/MS and selected bioassays to 
monitor chromatographic fractionation, we isolated and characterised two bioactivies, a novel PLA2 
and α3β2 nAChR blocker from the venom of hell’s fire anemone. The molecular weight of the 
isolated PLA2 was 14.7 kDa and showed homology to previously characterised sea anemone 
Condylactis gigantean PLA2. Interestingly, after 30 min incubation of the sheep RBC with the 
isolated toxin, the indentation edges appeared on the cell surfaces. This finding was consistent with 
the previous studies of the effect of PLA2 toxin on erythrocyte morphology changes and suggests 
the possible contribution role of this toxin to human envenomation symptoms. The isolated α3β2 
nAChR blocker was the first report of the presence of this toxin in anemone venom. This 
observation suggests that cnidarians may represent evolutionary precursors of nAChR of younger 
lineages. In this study the unique approach of investigating novel toxins from hell’s fire anemone, 
genus Actinodendron, has shed light upon the diversification and biodiscovery potential of its 
venom composition. 
Keyword 
Hell’s fire anemone, Actinodendron sp., activity-guided fractionation, therapeutics 
 
The hell’s fire anemone Actinodendron sp., UQBR Aquaria (GC Lawrence and M Jouiaei)  
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5.1 Introduction 
In the marine world, there are many venomous creatures utilising their toxins to capture and 
immobilise prey and/or for protection from predators. Amongst these animals are sea anemones, a 
group of predatory animals of the phylum Cnidaria, class Anthozoa. Although the majority of the 
sea anemones are harmless to human, few species are highly toxic producing a venomous cocktail 
that can cause severe neurotoxic, cytotoxic and hemolytic effects [279]. In spite of this, the 
biodiversity and the remarkable pharmacological properties of venom can be a valuable bioresource 
of potential drug candidates [73, 219]. 
The genus Actinodendron contains several sea anemone species which are found in the Indo-Pacific 
and coastal habitats. These animals are named “hell’s fire anemones” because of their highly potent 
venoms which can cause a very painful sting upon contact with human skin (unpublished data). 
Although their venom can have adverse impact on human activities, both recreational and 
occupational, the hell’s fire anemones have been poorly studied regarding their taxonomic status 
and venom composition. Until now, only one study has shown the pharmacological properties of 
the isolate sodium channel blocker toxin from an Actinodendron sp. [198], while neglecting the 
venom profile and biodiscovery potentials of its venom.  
Recent technological advances in proteomic and genomic (transcriptomic) techniques have 
provided a complete picture of the venom and a promising tool for drug discovery. Utilising these 
new and improved techniques has significantly increased our understanding of the remarkable 
venom complexity of several jellyfish species [14] (see chapter 3 and 4).  When genomic database 
(and therefore theoretical protein databases) is not available, activity-guided fractionation can be 
useful to facilitate characterisation of active toxins (bioactivies) in whole venom [146, 285]. For 
example, screening of the fractioned crude venom from Conus sp. resulted in the identification of a 
novel toxin [285]. This approach, although effective, considerably depends on advanced proteomic 
and screening techniques, thus it is time-consuming and relies on operator expertise for analysing 
complex data.  
In this study, a combination of chromatography, mass spectrometry and high-throughput screening 
(HTS) techniques were applied to identify bioactivies in the venom of hell’s fire Actinodendron sp. 
It should be mentioned that Actinodendron species-specific characteristics are not yet described; 
hence we name here the anemone just as Actinodendron sp. 
5.2 Result and Discussion  
5.2.1 Proteomics 
Given the lack of genomic information available, venom complexity was determined using an 
Orbitrap-based mass spectrometer. Crude venom analysis recovered several toxin types with 
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functional diversities consistent with predatory/defence effects including lethal effects upon 
cytolytic, cardiotoxic, hypertensive, hemorrhagic, allergic reaction and neurological function. These 
toxins showed a high diversity of molecular weight, ranging from small neurotoxins with less than 
10 kDa to larger proteins over 150 kDa (Table 5-1). To further investigate the biological properties 
of hell’s fire venom and isolate venom proteins of interest, crude venom was semi-fractioned using 
molecular weight cut-offs of 10 kDa and 30 kDa. The venom samples (< 10 and 10– < 30 kDa) 
were then analysed for bioactivity and subjected to RP-HPLC fractionation to isolate novel toxins. 
Table 5-1. Summary of venom proteins identified in Actinodendron sp. tentacle. 
Toxin Type Function 
Best Venom hit 
Accession # 
~MW 
(kDa) 
Enzymes 
Phospholipase A2 
Cytolytic, hemolytic, inflammation, prey 
digestion  [286] 
A7LCJ2 14-17 
Metalloproteinase Hemorrhagic toxin [287] Q3HTN2 67 
Peptidase M13 Cardiotoxic [288] E3PQQ8 23 
Pore forming toxins 
Actinoporin 
Cytolytic, hemolytic, cardiovascular and 
respiratory arrest [279] 
C9EIC7 20 
Membrane Attack 
Complex-Perforin 
Cytolytic, hemolytic [279] P58912 54 
Presynaptic pore forming 
toxin 
Insecticidal toxin that forms a membrane 
channel in the prey and induces massive 
neurotransmitter release [289] 
Q9XZC0 110 
Neurotoxins 
Acetylcholine receptor  
inhibiting toxin 
Neuromuscular and neuronal transmission 
impairing toxin [290] 
C6ZJQ2 8 
NaTx (Type I) Neurotoxic, cardiotoxic [279] B1NWT3 8 
Kunitz peptides Paralytic, serine protease inhibitor [279] P0DMJ4 6 
CaTxs Blocks contraction of smooth muscle [291] Q8JI38 26 
Others 
Venom allergen Causes an allergic reaction in human [292] Q9NH75 15 
Bradykinin-potentiating 
and natriuretic peptides 
Hypotensive and vasodepressor activity[293] P68515 18 
Venom factor Causes inflammatory responses [294] J3S836 180 
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5.2.2 Isolation of a Novel sPLA2 Toxin 
PLA2 activity has been quantified in representative species of all classes of the phylum Cnidaria 
[44], and several PLA2s have been described in detail in venom from the anemone Bunodosoma 
caissarum [295], Urticina crassicornis [296], Condylactis gigantean  and Adamsia palliate [93]. 
These venom proteins have a low molecular weight (14–17 kDa) and high content of disulfide 
bridges shown to be dependent on Ca
2
+ ion for enzymatic activity. While sea anemone PLA2 toxins 
share similar properties, such as cytolytic (e.g. hemolytic) due to their enzymatic activity they differ 
in respect to the number of cysteines which place them in various groups. In this regard the PLA2 
toxins from C. gigantea is more structurally similar to A. carcinoapados, than the toxins from C. 
gigantea and U. crassicornis [297].   In the present study Actinodendron sp. crude venom (10– < 30 
kDa) was shown to contain PLA2 toxin. Using sPLA2 Assay the enzymatic activity confirmed the 
presence of this enzyme. In order to isolate and obtain the PLA2, crude venom (10– < 30 kDa) was 
fractioned using offline RP-HPLC combined with LC-ESI-MS (Figure 5-1A–B). The molecular 
weight of each fraction was determined (data not shown) and fraction of interest with the molecular 
weight of 14–17 kDa was tested for its bioactivity.  Interestingly both crude and isolate venom 
protein showed similar enzymatic activity indicating maximum recovery of the protein during 
fractionation (Figure 5-1C–D).  
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Figure 5-1. Purification and identification of PLA2 from venom of Actinodendron sp. (A) RP-HPLC 
fractionation profile of the crude venom (10– < 30 kDa). Fractions were collected every min and subjected to 
ESI-MS for mass analysis. The peak indicated in blue (fraction 34) was tested further for its bioactivity using 
sPLA2 assay kit. (B) Molecular weight of the fraction of interest determined by LC-ESI-MS. (C) Absorbance 
times and (D) sPLA2 activity (µmol/min/mg) for crude venom (10– < 30 kDa) and fraction of interest. 
Values presented as a mean of three replicates (n = 3) and error bars indicate SD. 
Further, in order to identify the protein composition of the fraction with PLA2 activity and confirm 
the isolation of the toxin from Actinodendron sp., the fraction of interest was reduced, alkylated, 
trypsin digested and subsequently analysed using LC-Orbitrap MS/MS. Interestingly, the BLAST 
search of the MS/MS spectra identified the hell’s fire homologous PLA2 proteins in C. gigantea 
(Cgg2a) (Table 5-2, Appendix I).  Considering these observations, this is the first phospholipase 
A2 isolated from Actinodendron sp., which is likely to have sequence similarity with Cgg2a. 
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Table 5-2 Hell’s fire homologous PLA2 protein identified in the selected fraction. 
Protein Accession 
# 
Organism MW (Da) %Cov (95%)
a
 
 
Matched 
Peptides # 
(%95)
 b
 
PLA2-actitoxin-Cgg2a D2X8K2 Condylactis gigantea 13,637 100 1 
NOTE. Only proteins showing ≥ 95% matching confidence with at least 1 identified peptides from the 
Protein Pilot analysis were used.  
a
 The percentage of matching amino acids from identified peptides having confidence greater than or equal to 
95%;  
b 
The number of distinct peptides having at least 95% confidence. 
5.2.3 Possible Role of PLA2 in Abnormal RBC Morphologies 
Several studies have indicated the effect of PLA2s from snake, red-back spider, bee and blue-ringed 
octopus venoms on erythrocyte shape changes [298-300].  It has been proposed that separation of 
actin from the main cytoskeletal proteins is possibly responsible for the Red Blood Cell (RBC) 
remodelling from discocytes to formation of indentations, followed by haemolysis [298]. In this 
study, the effect of hell’s fire PLA2 on sheep red blood cells (sRBCs) was examined. Prior to venom 
treatment, the SRBCs were discocytes (Figure 5-2A). After treatment with the isolated toxin for 30 
min, the indentation edges appeared on the RBC surfaces (Figure 5-2B). The shape changes seen in 
this study were also present in previous studies, confirming the possible role of PLA2 in SRBC 
deformation. It is likely that the initiation of RBC shape changes before haemolysis occurs, as the 
venom most likely disturbs normal functioning of the blood in the vessels and contributes to organ 
impairment.  
 
Figure 5-2.  Light microscopy (LM) of sheep RBCs. (A) Control (un-treated) cells showing discocytes.  
(B) Venom treated cells after 30 min incubation at 37 °C showing indentation edges (arrows). Scale bar is 20 
µm. 
82 
5.2.4 Pharmacological Significance of Hell’s Fire Venom 
To assess the neurotoxic effects of venom, low molecular weight (< 10 kDa) venom components 
were examined across SH-SY5Y human neuroblastoma nicotinic acetylcholine receptors (nAChR) 
and various ion channels. An initial screening of the venom at a concentration of 5 µg/well revealed 
slight inactivation of Cav2.2
 
and α7 nAChR (Figure 5-3A–B) whilst no response was observed on 
Cav1.1
 
and Nav (Figure 5-3C–D). Interestingly, the same concentration of venom completely 
blocked α3β2 nAChR (Figure 5-3E). Hell’s fire venom did not block Nav (Nav1.2/1.3
 
and Nav1.7); 
however, the proteomic study suggests the presence of a NaTxs (Table 5-1). In addition, it has been 
shown that the isolated Nav toxin from hell’s fire venom has a strong inhibiting effect on 
crustaceans and conversely a very weak effect on mammals [198]. Thus future studies should 
determine specific blocking activity of the venom on the remaining Nav (Nav1.1/1.4/1.5/1.6/1.8
 
and 
Nav1.9) and invertebrate (insects and crustaceans) ion channels. If the isolated neurotoxin in our 
study can selectively block insect sodium channels, it may be used as a lead compound for the 
development of novel insecticides. 
 
Figure 5-3. Actinodendron sp. pharmacological activity. Low molecular weight (< 10 kDa) venom was 
screened for activity at (A) voltage-gated calcium channel Cav1.2, (B) α7-containing nicotinic receptors (α7 
nAChR), (C) Nav (D) Cav1.2
 
and (E) α3-containing nicotinic receptors (α3β2 nAChR) using the FLIPR® 
assay in SH-SY5Y cells. Note the concentration-dependent block of a3 nAChR, full block at 5 µg/well, 50% 
at 1 µg/well and ~20% at 0.2 µg/well. The data shown are normalised florescence responses over baseline 
after the addition of agonists (blue) plotted against time during assays.  
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To further purify and identify active fractions with α3β2 nAChR blocking activity, low molecular 
weight (< 10 kDa) venom was separated on RP-HPLC (Figure 5-4A). Each fraction was then 
examined for its activity. Our results demonstrate fractions 34–36 significantly inactivate the 
nAChR receptors (Figure 5-4B).  
 
Figure 5-4. Purification and identification of α3 nAChR blockers from venom of Actinodendron sp.  
(A) RP-HPLC fractionation profile of the low molecular weight (< 10 kDa) venom. (B) The resulting 62 1-
min fractions (F1–F62) were screened on α3 nAChR. Active fractions are highlighted in blue. 
In order to determine the protein composition of the active RP-HPLC fractions (F34–36), the 
corresponding peak was then manually collected and subjected to reduction, alkylation and trypsin 
digestion. Consistent with the nAChR blocking activity, the MS/MS spectra shows a homologous 
peptide to the venom of Conus pulicarius (Table 5-3, Appendix I). This homologous peptide acts on 
postsynaptic membranes, blocks α3β2 nAChR at 10 µM and causes goldfish death by flaccid 
paralysis [290]. In a recent study, paralytic peptides including nAChR were suggestive of a 
defensive strategy of Conus spp. [183].  It is therefore hypothesised that the novel nAChR toxin 
from hell’s fire anemone also could have a defensive role.  
Table 5-3 Hell’s fire protein identified in the selected fractions (F34–36). 
Protein Accession 
# 
Organism MW (Da) %Cov (95%)
a
 
 
Matched 
Peptides # 
(%95)
 b
 
α-conotoxin C6ZJQ2 Conus pulicarius 7,510 100 2 
NOTE. Only proteins showing ≥ 95% matching confidence with at least 1 identified peptide from the 
Protein Pilot analysis were used.  
a 
The percentage of matching amino acids from identified peptides having confidence greater than or equal to 
95%;  
b
The number of distinct peptides having at least 95% confidence. 
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5.2.5 Biodiscovery Potentials of Hell’s Fire Venom 
In this study a highly potent α3β2 nAChR blocking toxin with homology to α-conotoxins was 
identified by using advanced proteomics and screening techniques. The nAChR antagonist peptide 
in Conus spp. (α-conotoxins) is postulated to have applications in smoking cessation, treating mood 
disorders and muscle relaxation during surgery [301]. In addition, nAChR antagonists have been 
suggested to represent novel class of antidepressants [302]. Given the similarity of the anemone 
toxin to α-conotoxin, by optimising its biophysical properties, it can find applications in treating 
human diseases or can become a valuable probe for studying α3β2 nAChR in normal and 
pathophysiological conditions.  
5.3 Conclusion and Future Directions 
The principle aim of this study was to identify novel bioactivies from the venom of hell’s fire 
anemone Actinodendron sp. Considering the absence of transcriptomic data (as we used for the box 
jellyfish and blubber jelly venom in chapter 3 and 4), activity-guided fractionation was significantly 
useful to identify novel toxins. The chromatographic methods in the present study resulted in a 
purified PLA2 and nAChR blocker and showed to be efficient for the isolation of these toxins from 
Actinodendron sp. Also novel receptor activity on mammalian cell lines is strongly suggestive of 
the untapped pharmaceutical and biodiscovery pipelines relevant to this anemone. Furthermore, 
identification of a nAChR blocker from sea anemone with homology to α-conotoxins from 
evolutionary younger lineage cone snail, suggest that this toxin may evolve at the base of 
eumetazoan venom evolution, and cnidarians may be considered evolutionary precursor of nAChR 
of higher animals.  
The results of this study highlight the biodiscovery potential of this genus and emphasises the need 
for future de novo sequencing of the PLA2 and neurotoxic peptides in hell’s fire anemones.  
5.4 Experimental Section 
5.4.1 Specimen and Venom Collection 
Four mature live specimens of Actinodendron spp. were purchased from Salty Pets LTD in March 
2015. They were transported live to the University of Queensland and were held in aquarium for 
over a year at a temperature maintained between 24–28 °C and a 12:12 light–dark cycle.  In order to 
obtain venom sample, the equal proportion of fresh tentacles from each specimen were collected 
manually and pooled to remove the effect of individual variability. The pooled samples were milked 
by ethanol induced discharged as previously described [14] (see chapter 3 and 4). 
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5.4.2 Proteomics  
5.4.2.1 LC−Orbitrap Elite MS/MS 
Crude venom and RP-HPLC fractions of interest were reduced/alkylated and enzymatically 
digested as previously described (see chapter 3). The samples were separated using reversed-phase 
chromatography on a Dionex Ultimate 3000 RSLC nano-system.  Using a flow rate of 30 µl/min, 
samples were desalted on a Thermo PepMap 100 C18 trap (0.3 × 5 mm, 5 µm) for 5 min, followed 
by separation on a Acclaim PepMap RSLC C18 (150 mm × 75 µm) column at a flow rate of 300 
nL/min.  A gradient of 10–95% buffer B over 7 and 90 min (for fractions and crude venom 
respectively) where buffer A = 1% ACN/0.1% FA and buffer B = 80% ACN/0.1% FA was used to 
separate peptides.  Eluted peptides were directly analysed on an Orbitrap Elite mass spectrometer 
(Thermo) using an NSI electrospray interface.  Source parameters included a capillary temperature 
of 275 °C; S-Lens RF level at 60%; source voltage of 2 kV and maximum injection times of 200 ms 
for MS and 150 ms for MS2. Instrument parameters included an FTMS scan across m/z range 350–
1800 at 60,000 resolution followed by information dependent acquisition of the top 10 peptides 
across m/z 40–1800.  Dynamic ion exclusion was employed using a 15 second interval.  Charge 
state screening was enabled with rejection of +1 charged ions and monoisotopic precursor selection 
enabled. Data was converted to mascot generic format (mgf) using the msConvert software 
(ProteoWizard) and searched against ToxProt database using Protein Pilot™ v5.0 (Sciex). The 
detected peptide fragments (confidence value ≥ 95% with 1 or more matched peptides) were 
manually inspected and validated. 
5.4.2.2 Reverse Phase High Performance Liquid Chromatography (RP-HPLC) 
Whole venom was diluted with MilliQ water and semi fractioned using Visaspin Concentrators (GE 
Healthcare, UK) with a molecular weight cut-off of 10 and 30 kDa. The semi fractioned venom (< 
10 kDa and > 10– < 30 kDa) were separated further using reversed-phase chromatography liquid 
chromatography on a Shimadzu Prominence modular HPLC system. Using a flow rate of 1ml/min 
samples were separated on a C18 column (ZOBRAX 300SB-C18 5μm 4.6 × 250 mm). A gradient 
of 0–60% over 60 min buffer B where buffer A = 0.05% TFA and buffer B = 90% ACN/0.043% 
TFA was applied and 60 fractions for each semi-fractioned venom were collected, lyophilised and 
store at –80 °C. 
5.4.2.3 uHPLC, Electrospray Mass Spectrometry and Mass Profiling (LC-ESI-MS) 
 In order to obtain a complete mass list of intact proteins, the fractions for both < 10 kDa and  10– < 
30 kDa samples were analyzed by uHPLC-MS on a Nexera uHPLC (Shimadzu, Japan) coupled to a 
Triple TOF 5600 mass spectrometer (SCIEX, Canada) equipped with a duo electrospray ion (ESI) 
source. Twenty µl of each extract was injected onto a 2.1 mm × 100 mm Zorbax 300 SB, C18 
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1.8um column (Agilent, USA) at 200 µl/min. Linear gradients of 2–60% solvent B over 6 min 
followed by a steeper gradient from 60% to 98% solvent B in 1 min were used for protein elution. 
Solvent B was held at 98% for 1 min for washing the column and returned to 2% solvent B for 
equilibration prior to the next sample injection. Solvent A consisted of 0.1% FA (aq) and solvent B 
contained 90/10 ACN/0.1% FA (aq). The ionspray voltage was set to 5300 V, declustering potential 
(DP) 100 V, curtain gas flow 25, nebuliser gas 1 (GS1) 45, GS2 to 50, interface heater at 150 
o
C 
and the turbo heater to 500 
o
C. The mass spectrometer acquired 500ms full scan TOF-MS data over 
the mass range 500–2200. The data was acquired and processed using Analyst TF 1.6 software 
(SCIEX, Canada).  
5.4.3 Bioassay 
5.4.3.1 PLA2 assay 
10 µl aliquots (100 µg) of the semi-fractioned venom (10– < 30 kDa) and RP-HPLC fraction of 
interest were assayed using sPLA2 Assay Kit (Cayman Chemical Company, Ann Arbor, MI, USA), 
as previously described (see chapter 4).  
5.4.3.2 RBC Preparation and Light Microscopy of Shape Changes 
 Sheep red blood cells (defibrinated) were obtained from Thermo Scientific ™. The cells were 
washed twice (5 min, 500 × g, 4 °C) in a Veronal Buffered Saline (VBS) (HEPES 10 mM, NaCl 
145 mM, pH 7.4) at 1:4 sRBC: buffer ratio. Ten µg of the isolate PLA2 toxin was diluted with 10 µl 
VBS before incubating with SRBC for 30 min at 37 °C. Blood films were prepared on glass slides 
with control and venom-incubated sRBCs. The slides were then observed by differential 
interference contrast microscopy (40 × magnification). 
5.4.3.3 Fluorescence-Based HTS Assay  
The ion channel activity of semi-fractioned venom (< 10 kDa) and RP-HPLC fractions were 
assessed using the human neuroblastoma SH-SY5Y cells and high-throughput Ca
2+
 imaging assays, 
as previously described [183]. SH-SY5Y cells (European Collection of Cell Cultures) endogenously 
express human voltage gated sodium (Nav1.2/ Nav1.3 and Nav1.7), voltage gated calcium (Cav1.1 
and Cav2.2), and nicotinic acetylcholine (α3β2, α3β4 and α7 nAChR) channels. Briefly, cells were 
routinely maintained at 37 °C in RPMI complemented with 15% fetal bovine serum and L-
glutamine medium (Invitrogen, Australia) and passaged every 3–4 days or when ∼80% confluent 
using 0.25% trypsin/EDTA (Invitrogen). Prior to activity assays, cells were plated on 384-well 
black-walled imaging plates (Corning) at a density of 35,000–50,000 cells per well.  They were 
incubated for 30 min with fluorescent Ca
2+
 dye (Calcium 4 No Wash dye, Molecular Devices) 
diluted with buffer containing (mM) NaCl 140, 
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glucose 11.5, KCl 5.9, MgCl2 1.4, NaH2PO4 1.2, NaHCO3 5, CaCl2 1.8, HEPES 10. Fluorescent 
responses (excitation 470–495 nm; emission 515–575 nm) were monitored for 550 s using a 
FLIPR
Tetra
 fluorescent plate reader (Molecular Devices, Sunnyvale, CA, USA). A total of 60 
fractions and 50 ug of the semi-fractioned venom (< 10 kDa) were added to the cell plate in 
triplicates and incubated for 5 minutes prior to stimulation of channel isoforms with the selected 
agonists. The agonists included veratridine (50 μM) for Nav1.2/ Nav1.3, scorpion toxin OD1 in 
combination with veratridine for Nav1.7, KCl (90 mM) and CaCl2 (5 mM) for Cav1.1 and in the 
presence of nifedipine (10 μM) for Cav2.2, Nicotine (30 μM) for α3β2, and choline (30 μM) in the 
presence of the allosteric modulator PNU120596 (10 μM, Sigma-Aldrich) for α7 nAChR. 
Florescence responses were normalised to baseline using ScreenWorks 3.2.0.14 (Molecular 
Devices) and the maximum increase in fluorescence for each venom fraction was plotted using 
GraphPad Prism 5.03.  
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6.1 Research Overview 
Despite being the most ancient venomous animals, cnidarians are largely uninvestigated. The aim of 
this thesis was to provide the first comprehensive insight into the molecular evolutionary history 
and biodiscovery potential of these distinctive organisms. With a unique venom delivery system and 
fascinating venom evolution, cnidarians harbour an interesting pool of unstudied toxins that may 
represent an attractive resource in the search for leading therapeutics. This research adopted state-
of-the-art molecular evolutionary, morphological, and venomics approaches to depict these ancient 
venomous animals and illuminate their evolutionary history. In addition, in order to overcome the 
time and labour intensive complications involved in extracting venom from these magnificent 
animals, a cost-effective and rapid venom extraction technique was developed to expedite the 
discovery of novel venom proteins. 
6.1.1 Evolution of an Ancient Venom 
Understanding the evolutionary forces shaping venom proteins and their diversity is vital to unwind 
their full biodiscovery potential, particularly in the ancient venomous lineages such as Cnidaria. 
Molecular evolutionary assessments in this thesis revealed that several pore-forming toxins 
(aerolysin-related toxins in sea anemones and hydroids, actinoporins and jellyfish toxins) evolved 
under the heavy constraints of negative/purifying Darwinian selection.  These toxin types create 
non-selective membrane pores by forming oligomeric transmembrane complexes via the interaction 
of several structurally important residues (e.g. the N-terminal α-helix, basic amino acids, and 
aromatic residues).  As a result, to ensure the necessary transformation from a monomeric protein to 
an oligomeric complex, pore-forming toxins remain evolutionarily constrained. Similarly, 
corresponding assessments indicated that sea anemone neurotoxins (NaTxs, KTx type I) and 
Scleractinian coral neurotoxins (SCRiPs) also experience an extreme influence of negative selection 
to favour the conservation of structurally important residues. 
Another striking finding was the influence of positive selection on the evolution and diversification 
of type III KTxs from NaTxs within the Actinioidea superfamily of sea anemones. When venomous 
animals such as cnidarians experience interactions with novel prey and predators in new ecological 
niches, several sites on the toxin molecular surface undergo episodic bursts of adaptive selection, 
while the core residues involved in stability remain conserved. The accumulation of variations can 
lead to the emergence and diversification of novel toxins, and these may exhibit new 
pharmacological activities that favour an affinity for the molecular physiology of newly- 
encountered prey and predators.   Interestingly, it appears that the rapid generation of novel toxin 
types in Actinioidea under positive Darwinian selection could be increasing the efficiency and 
potency of the venom, possibly in response to shifts in feeding ecology.  
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Overall, these findings unravelled the molecular evolution, diversification, and phylogenetic 
histories of toxin families in cnidarians, and highlight the role of negative and episodic selections in 
shaping their venoms. In brief, the influence of negative selection could be advantageous in this 
lineage to ensure the preservation of venom potency for extended periods of time over the course of 
their evolutionary history. In contrast, the rapid diversification and generation of novel toxins could 
expand the range of molecular targets and successful adaptation to the new ecological niches over 
shorter timeframes.  
6.1.2 Cnidarian Venom Extraction  
In spite of recent efforts from toxinologists to identify cnidarian venom protein and peptides, our 
knowledge of their venom composition and biodiscovery potential is still incomplete. Of the 
approximately 10,000 cnidarian species in existence, the ToxProt data bank currently contains 272 
reviewed toxins, of which the majority are neurotoxins and pore-forming toxins from sea anemones. 
A major obstacle in cnidarian venom research is the difficulty in obtaining sufficient quantities of 
pure venom in a time and cost effective manner. As part of an initial strategy, a novel venom 
extraction method was designed to facilitate the discovery of venom-encoding sequences in three 
representative species from three classes: the box jellyfish Chironex fleckeri (Cubozoa) (Chapter 3), 
Blubber jelly Catostylus mosaicus (Schyphozoa) (Chapter 4) and hell’s fire anemone 
Actinodendron sp. (Anthozoa) (Chapter 5). This method involved the application of ethanol on the 
live tentacles of these species to induce nematocyst discharge. The utilisation of this chemical 
stemmed from the common knowledge that exposure to alcohol can worsen cnidarian envenomation 
symptoms in some of the medically important species such as box jellyfish. This approach would 
cause an explosive discharge of nearly all the nematocysts’ venom components, conferring the 
advantage of being rapid and cost-effective. This has undoubtedly advanced current knowledge of 
cnidarian venom. In addition, given the insights obtained in the fifth chapter, ethanol-extracted 
venom can be used for activity-driven analyses. However, this new method in addition to its 
strengths raises the question whether venom collected in that manner would be expected to have the 
same recovery, toxicity and activities in comparison to previously published methods (e.g., 
pressure-disrupted venom). Depending on the objective of the study, future studies could investigate 
the venom recovery in terms of percentage discharge of nematocysts and relative toxicity in terms 
of hemolytic units (HU50) [3]. Overall, it is anticipated that this novel method will stimulate interest 
in cnidarian venom research and will be employed broadly in other laboratories, increasing potential 
for the production of appropriate antibodies or therapies for human envenomation.  
 
91 
6.1.3 Biodiscovery Potential of Cnidarian Venoms Using Transcriptome/Proteome 
Sequencing, Activity-Guided Fractionation and Molecular Evolutionary Approaches 
While the majority of studies target medically-important or abundant organisms for ethical or 
practical reasons, research on rare organisms or less-studied species often provides a promising 
source of novelty. In this regard, recent advances in high-throughput transcriptome and peptide 
sequencing, as well as activity screening techniques, have provided an efficient and robust set of 
tools for identifying novel therapeutics from animal venoms.  
 In this thesis work, the integration of transcriptomic and proteomic data, using next generation 
transcriptome sequencing technologies coupled to modern tandem MS/MS techniques, resulted in 
the expansion of identified box jellyfish venom components, as well as the characterisation of 
blubber jelly venoms for the first time. Currently, this strategy is limited by the lack of a 
comprehensive cnidarian transcriptome database to match against the peptide sequence tags 
obtained by MS/MS. In addition, final matching MS data to custom reference database requires 
proper bioinformatics tools. Protein Pilot™ software (Sciex), although expensive, is one of the few 
tools available in this regard. Another limitation in matching transcriptomes and proteomes is the 
presence of protein isoforms that share identical peptide fragments, resulting in a low number of 
matches and high false discovery rate that is not suitable for publication purposes.  
An alternative approach when transcriptome data is not available could be utilising activity-guided 
fractionation (chromatography/tandem mass spectrometry/bioassays) to facilitate identification of 
active toxins from non-model organisms. This approach has been utilised in this work with the 
analysis of hell’s fire anemone, Actinodendron sp. venom, which enabled the discovery of the first 
α3β2 nAChR blocker. This novel toxin could be a promising potential therapeutic lead in treating 
mood disorders or facilitating muscle relaxation during surgery.   
In any case, the mentioned approaches highlight the importance of accessibility to substantial 
amount of fresh material (e.g. tentacle tissue and venom proteins) and high-priced equipments. An 
innovative strategy to discover novel toxins could entail molecular evolutionary assessments of the 
translated nucleotide and protein sequences available in the databases, such as GenBank and 
UniProt. Employing state-of-the-art molecular evolutionary analyses complemented with bioassay 
techniques, we identified the first neurotoxin family from stony corals (order Scleractinia), which 
appears to have been recruited into their venom nearly 500 million years ago (Chapter 2). 
6.2 Conclusion/Future directions 
While the works presented here provide the first comprehensive insight into the evolution of 
cnidarian venoms, it also increases biodiscovery potential and provides direction for future research. 
There is currently no information on the effect of ecological niches on venom composition. This 
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gap in knowledge begs further investigation in order to fully understand the evolutionary forces that 
shape venom. In addition, although developing a rapid and novel venom extraction technique by 
using ethanol will facilitate future cnidarian venom research, it presents the question of whether 
different venom extraction techniques produce significantly different crude venoms. This could be 
investigated by using more advanced proteomics techniques, such as SWATH-DIA (unbiased 
“data-independent acquisition”) [303-305], to provide a unique and accurate label-free 
quantification of the venom proteins and peptides in various experimental conditions.  The vast 
number of proteins and peptides uncovered in this work also gives an indication of the depth of 
biodiversity yet to be revealed in cnidarian venoms.  
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XXI 
APPENDIX I 
 
Ions recovered from isolated venom proteins from hell’s fire anemone Acinodendron sp. using 
tandem mass spectrometry. Green indicates the percentage of matching amino acids from identified 
peptides having confidence greater or equal to 95%. 
 
PLA2, Accession number D2X8K2 
GVWQFAYMIAKYTGRNPLDYWGYGCWCGLGGKGNPVDAVDRCCYVHDVCYNSITQGPRPTCSRIAP
YHKNYYFTGKKCSTGWLTSKCGRAICACDIAAVKCFRRNHFNKKYRLYKKNIC 
Conf Sequence ∆Mass Theoretical MW z 
95.23 NPLDYWGYGCWCGLGGKGNPVDAVDR 0.086362 2926.280273 3 
nAChR blocker, Accession number C6ZJQ2 
MGMRMMFAVFLLVVLATTVVSFNSDRASDGRNAAANVKASDLMARVLEKDCPPHPVPGMHKCVCLK
TCR 
Conf Sequence ∆Mass Theoretical MW z 
98 ASDGRNAAANVKASDLMAR 
 
0.005026 
 
1916.948608 4 
99 
 
NAAANVKASDLMAR 
 
 
0.049535 
 
1522.756226 3 
NOTE. Only proteins showing ≥ 95% matching confidence with at least 1 identified peptides from the 
Protein Pilot analysis were used.  
 
 
